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Abstract 
 
 Methamphetamine is one of the most neurotoxic and addictive 
drugs of abuse.  While prenatal exposure to all illicit drugs is considered 
detrimental, it might be argued that because of the polydrug nature of 
methamphetamine and the harmful effects that physical exposure to the 
substance can produce, it is perhaps even more damaging, or damaging 
in a different manner, than other drugs when used by pregnant women.  
Few studies have focused on the effects of prenatal exposure to 
methamphetamine alone or methamphetamine when combined with or 
compared to other substances.  Additionally, no study has focused solely 
on the differences in the cognitive, language, motor, emotional 
functioning, behavioral functioning, and head circumference of young 
children prenatally exposed to methamphetamine only, young children 
prenatally exposed to methamphetamine plus other substances, and 
young children prenatally exposed to other substances not including 
methamphetamine.  The present study attempted to address these 
issues by utilizing archival data from a specialty clinic in a large 
Southwestern city to which children, aged 1-month to 7-years, were 
referred specifically because of their prenatal exposure to substances.  
1,556 records of children met inclusion criteria, although many of the 
records did not include data from all assessment measures.  The 
  x
subjects received a standardized battery of tests to determine their 
cognitive, language, motor, emotional and behavioral functioning, and 
physical development. Although no significant differences were found 
between exposure groups on scores of cognitive development, emotional 
development, and behavioral development, a nonsignificant difference 
(p< .069) was found for language development.  Additionally, significant 
differences were found between exposure groups on scores of motor 
development and head circumference measurements.  This suggests 
that prenatal exposure to methamphetamine is as harmful as prenatal 
exposure to other substances; however, it does not appear to cause 
increased cognitive, language, emotional, or behavioral damage, nor 
does it appear to compound the effects of other drugs.  However, 
findings of significant differences in the motor development and head 
circumference categories seem to indicate that these areas may be at 
risk of increased damage through prenatal exposure to 
methamphetamine.  The current study was limited by lack of a control 
group, an inability to control for environmental exposure to drugs and 
alcohol, and retrospective, maternal and second-party report. 
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Chapter 1 
Introduction 
 The use of methamphetamine has become a significant problem 
in the United States over the past two decades.  According to the 2007 
National Survey on Drug Use and Health (NSDUH), approximately 13 
million Americans 12 years or older reported using methamphetamine at 
least once during their lifetimes.  This represents 5.3% of the population 
aged 12 or older.  While national surveys have shown recent declines in 
methamphetamine abuse among U.S. youth, evidence from emergency 
departments and treatment programs attest to the growing impact of 
methamphetamine abuse in the country (NSDUH). 
 The Drug Abuse Warning Network (DAWN), which collects 
information on drug-related episodes from hospital emergency 
departments (EDs) throughout the nation, has reported a greater than 
50% increase in the number of ED visits related to methamphetamine 
abuse between 1995 and 2002, reaching approximately 73,000 ED 
visits, or 4% of all drug-related visits in 2004.  In that same year, 45% of 
the primary admissions to substance use treatment for 
methamphetamine use were for women, compared to approximately 
26% of the primary admissions to substance use treatment for alcohol 
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abuse and for marijuana use (NSDUH, 2007).  Unfortunately, pregnant 
women are included in this trend. 
 Research has shown that the highest rate of methamphetamine 
use occurs in the 18-25 age groups (Nordahl, Salo, & Leamon, 2003; 
NIDA, 2006).  Additionally, in a study on methamphetamine use, 5.2% of 
1,632 women reported using the drug while pregnant (Arria et al., 2006).  
Furthermore, the prevalence of methamphetamine use in pregnant 
women appears to be comparable to the national prevalence of 
methamphetamine use in women who are not pregnant (Meredith, Jaffe, 
Ang-Lee, & Saxon, 2005). 
 Cause and effect has not been clearly delineated regarding 
ingestion of certain drugs during pregnancy and human birth defects.  
However, all illicit drugs that are taken during pregnancy reach the fetus 
once they cross the placenta.  Therefore, the effects of drugs on the 
fetus may be caused directly through the drug’s transfer through the 
placenta or may be secondary to changes in the fetal environment 
(Plessinger, 1998). 
 Methamphetamine has vasoconstrictive effects that result in 
decreased uteroplacental blood flow, fetal hypozia, and anorexic effects 
on the mother, possibly resulting in intrauterine growth retardation 
(Plessinger, 1998).  Adding to the confusion, although using certain 
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drugs while pregnant increases risks of adverse outcomes, birth defects 
are not an “all-or-none phenomena” (Plessinger, p. 120).  However, birth 
malformations have been reported in the infants of mothers who have 
abused amphetamine or methamphetamine during pregnancy 
(Plessinger). 
 Adverse outcomes including prematurity (Eriksson, Larsson, 
Winbladh, et al., 1978), stillbirth (Eriksson, Larsson, Winbladh, et al., 
1978; Stewart & Meeker, 1997), low birth weight (Little, Snell, & Gilstrap, 
1988; Oro & Dixon, 1987), growth reduction (Eriksson, Larsson, & 
Zetterstrom, 1981; Little, Snell, & Gilstrap; Oro & Dixon), reduced head 
circumference (Eriksson, Larsson, & Zetterstrom, 1981; Little, Snell, & 
Gilstrap; Oro & Dixon), cleft lip (Little, Snell, & Gilstrap; Milkovich & van 
den Berg, 1977; Nelson & Forfar, 1971; Saxen, 1975; Thomas, 1995), 
cardiac defects (Little, Snell, & Gilstrap; Nelson & Forfar; Nora, 
McNamara, & Clarke-Fraser, 1968; Nora, Vargo, Nora, et al., 1970), 
biliary atresia (Golbus, 1980; Levin, 1984), hyperbilirubinemia requiring 
exchange transfusion (Eriksson, Larsson, Winbladh, et al., 1978), 
cerebral hemorrhage (Dixon & Bejar, 1989), low body fat (Little, Snell, & 
Gilstrap), undescended testes (Little, Snell, & Gilstrap), systolic murmur 
(Little, Snell, & Gilstrap), and mongolian spots (Little, Snell, & Gilstrap) 
have been associated with maternal use of the substance. 
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 Additionally, according to one study, it was found that three infants 
born with oral clefts were known to be exposed to amphetamines on the 
43rd and 50th days of gestation.  These days are reported to be crucial in 
oral facial development (Plessinger, 1998).  Furthermore, research has 
found that the physical effects of prenatal methamphetamine use may 
include such complications as premature labor and delivery, cardiac and 
brain abnormalities, separation of the placenta, and altered behavioral 
patterns in infants such as irritability and abnormal reflexes (NIDA, 
2006). 
 Although cleft lip and cleft palate have not been reported in infants 
prenatally exposed to cocaine, these birth defects have been found in 
five incidences of prenatal amphetamine exposure (Plessinger, 1998).  
Many cardiovascular effects, such as bradycardia and tachycardia, 
resolve in newborns that have been prenatally exposed to amphetamine 
or methamphetamine.  However, some visual cognitive effects and 
behavior changes appear to be permanent (Plessinger).  Furthermore, 
visual recognition memory, which has been correlated with subsequent 
IQ, was found to be lower in infants with prenatal stimulant exposure 
(Hansen, Struthers, & Gospe, 1993). 
 Finally, because many pregnant women also use different 
combinations of other psychoactive drugs, there is also the risk of 
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combined impact on the physical, cognitive, and emotional development 
of the fetus (Wouldes et al., 2004). 
Current Study 
Problem Statement 
 Of women who use illicit drugs in the United States, approximately 
half are in the childbearing age group (NIDA, 1996).  It has also been 
noted that female addicts frequently exhibit a marked desire to have a 
baby (Weir, 1972).  In 2004, 8% of treatment admissions were for the 
abuse of stimulants, and 99% of all stimulant admissions were for 
methamphetamine or amphetamine abuse.  According to the Alcohol 
Drug and Pregnancy Team (ADAPT) at National Women’s Hospital in 
New Zealand, widespread methamphetamine use is also climbing 
among pregnant women in that country.  In 2001, the total number of 
referrals due to methamphetamine use was 10%; a number that 
escalated to 59% just two years later (Wouldes, LaGasse, Sheridan, & 
Lester, 2004). 
 In 1993, the largest study specifically focusing on the prevalence 
of alcohol, tobacco, and other substance use during pregnancy was 
conducted.  Because the methamphetamine problem did not emerge 
until the mid to late 1990s, less than 1% of pregnant women in the study 
had used methamphetamine during pregnancy (Arria et al., 2006).  
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Unfortunately, while the National Survey on Drug Use and Health could 
report on past month illicit drug use by 4.3% of pregnant women between 
the ages of 15 and 44 years, the estimates were conservative because 
they only reflect past month substance use during pregnancy, not 
substance use at any point during pregnancy.  These estimates of past 
month substance use reflected use among women who were pregnant at 
the time of the survey, not among all pregnant women in 2002 or 2003 
(NSDUH, 2005).  Furthermore, the Pregnancy Risk Assessment 
Monitoring System (PRAMS), which is funded by the Centers for Disease 
Control (CDC), provides estimates of alcohol and tobacco use only 
during the last 30 days of pregnancy and does not inquire about the illicit 
use of substances (Arria et al., 2006). 
 While we know that prenatal exposure to all illicit drugs is 
detrimental, it might be argued that because of the polydrug nature of 
methamphetamine and the harmful effects that physical exposure to the 
substance can produce, it is perhaps even more damaging, or damaging 
in a different manner, than other drugs when used by pregnant women.  
Few studies conducted up to this time focused on the effects of prenatal 
exposure to methamphetamine alone or methamphetamine when 
combined with or compared to other substances.  Moreover, they had 
small samples and other limitations or confounding factors.  The largest 
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prenatal methamphetamine exposure study to date, the Infant 
Development, Environment, and Lifestyle study (IDEAL; Arria et al., 
2006) is longitudinal and just in the early phases of examining data on 
the participants.  Prior to the current study, no study focused solely on 
the differences in the cognitive, language, motor, emotional functioning, 
behavioral functioning, and head circumference of young children 
prenatally exposed to methamphetamine only, young children prenatally 
exposed to methamphetamine plus other substances, and young 
children prenatally exposed to other substances not including 
methamphetamine. 
 The present study attempted to address these issues by utilizing a 
large database of scores on children who were referred to a specialty 
clinic specifically because of their prenatal exposure to substances.  The 
children presented at various ages, from 1 month to 7 years of age, and 
received a standardized battery of tests to determine their cognitive, 
language, motor, emotional and behavioral functioning, and physical 
development.  Information was also gathered regarding demographics 
and the specific drug(s) to which they were prenatally exposed. 
 The hope was that by comparing children with prenatal 
methamphetamine exposure with children who have been prenatally 
exposed to methamphetamine plus other substances, and prenatally 
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exposed to other substances not including methamphetamine we might 
discover information that could prove helpful for those who provide early 
intervention services.  For example, when children presented for 
assessment at the facility in this study, those with fetal alcohol exposure 
were given the opportunity to participate in a specialized behavioral 
treatment program and receive monetary compensation for their 
participation, as this treatment is part of an FAS research grant.  These 
opportunities were directly related to research finding behavioral 
difficulties in children with prenatal alcohol exposure. 
 We did not know whether or not children with prenatal 
methamphetamine exposure experience the same types of difficulties or 
delays that children with prenatal exposure to alcohol and/or other 
substances experience.  Knowledge of specific prenatal exposure could 
help professionals to be especially observant in particular areas (such as 
cognition, language, motor, emotional functioning, or behavioral 
functioning) and perhaps conduct additional evaluations in the suspected 
problem area.  Additionally, once the children at the facility in this study 
reach school age, they become reliant upon the public school system for 
developmental and behavioral services.  Caregivers, as well as the 
school system, could benefit if a specific domain is listed as being a 
potential problem area in the future.  For example, when there are 30 
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young children in a class, acting out because of language difficulties can 
look much like acting out because of behavior difficulties.  Children may 
be labeled as “troublemakers,” when the fact is they may be suffering 
from delayed problems due to prenatal drug exposure.  Understanding 
the early and future difficulties that may be faced by children whose 
mothers engaged in prenatal substance abuse, particularly 
methamphetamine, could help to fill in the gaps that currently exist in the 
literature, as well as prove helpful for those who provide early 
intervention services. 
Research Questions 
 The research questions addressed in this study included the 
following: (1) Are there differences in the cognitive scores of children 
who have been prenatally exposed to methamphetamine only, children 
who have been prenatally exposed to methamphetamine plus other 
substances, and children who have been prenatally exposed to other 
substances not including methamphetamine?  (2) Are there differences 
in the language scores of children who have been prenatally exposed to 
methamphetamine only, children who have been prenatally exposed to 
methamphetamine plus other substances, and children who have been 
prenatally exposed to other substances not including 
methamphetamine?  (3) Are there differences in the motor scores of 
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children who have been prenatally exposed to methamphetamine only, 
children who have been prenatally exposed to methamphetamine plus 
other substances, and children who have been prenatally exposed to 
other substances not including methamphetamine?  (4) Are there 
differences in the emotional functioning scores of children who have 
been prenatally exposed to methamphetamine only, children who have 
been prenatally exposed to methamphetamine plus other substances, 
and children who have been prenatally exposed to other substances not 
including methamphetamine?  (5) Are there differences in the behavioral 
functioning scores of children who have been prenatally exposed to 
methamphetamine only, children who have been prenatally exposed to 
methamphetamine plus other substances, and children who have been 
prenatally exposed to other substances not including 
methamphetamine?  (6) Are there differences in the head circumference 
measurements of children who have been prenatally exposed to 
methamphetamine only, children who have been prenatally exposed to 
methamphetamine plus other substances, and children who have been 
prenatally exposed to other substances not including 
methamphetamine? 
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Objective 
 The objective of this study was to ascertain whether or not 
differences emerged between the cognitive, language, motor, emotional, 
and behavioral scores, and head circumferences of children who have 
been prenatally exposed to methamphetamine only, children who have 
been prenatally exposed to methamphetamine plus other substances, 
and children who have been prenatally exposed to other substances not 
including methamphetamine. 
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Chapter 2 
Literature Review 
History of Methamphetamine 
 Methamphetamine is a stimulant that affects the central nervous 
system (CNS).  Legally available only through a prescription that cannot 
be refilled, methamphetamine is highly addictive and has a high potential 
for abuse.  Medical uses of methamphetamine are limited, with 
prescribed doses much lower than the amounts that are typically abused 
(National Institute on Drug Abuse, NIDA, InfoFacts, 2008). 
 First synthesized in the early 1900’s, amphetamines, including 
methamphetamine, were identified for medical use and manufactured in 
the 1930s as a bronchial dilator.  Later they would be prescribed for 
other conditions such as narcolepsy, attention deficit disorder, obesity, 
and fatigue.  As drug abuse became an increasing problem in the 1950s 
and 1960s, methamphetamine labs emerged in California’s Bay Area 
with motorcycle gangs such as the Hells Angels taking control of the illicit 
market (Meredith et al., 2005). 
 In 1970, amphetamine and methamphetamine were made 
Schedule II substances, which meant they had a high potential for abuse 
and were available only through prescriptions that could not be refilled 
(Hanson, 2002).  Bay Area biker groups initially used the “P2P method” 
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of methamphetamine synthesis (principal chemicals included phenyl-2-
propanone, aluminum, methylamine, and mercuric acid).  However, 
development of strict federal controls of P2P in 1988 made this method 
much less profitable.  Consequently, the P2P method was replaced by a 
cheaper, simpler, and more efficient process known as the 
ephedrine/pseudoephedrine reduction method, or “Nazi method,” which 
results in a much purer yield of the D-isomer of methamphetamine 
(Meredith, et al., 2005). 
 Elemental lithium, isolated from rechargeable camera batteries, 
can also be used as a catalyst in the ammonia/alkali method of reducing 
ephedrine into methamphetamine.  This chemical reduction results in the 
production of “crank,” a name that was derived from bikers using the 
crank cases of their motorcycles to transport the substance.  This 
method, in which precursor compounds can be easily diverted from 
legitimate use, gave birth to the advent of “superlabs,” which have the 
capacity to produce ten or more pounds of methamphetamine in one 
production cycle (Meredith et al., 2005).  As a result, while 
methamphetamine’s popularity faded somewhat in the 1970s, due to 
restrictions on prescriptions and the chemicals needed for its 
manufacture, the 1980s witnessed the reappearance of 
methamphetamine, beginning in Hawaii and the West (Hunt, Kuck, & 
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Truitt, 2006).  Throughout the 1990s, use of methamphetamine 
continued to grow steadily in the West and Northwest and by 2000 had 
reappeared in many Midwestern and Southern areas.  It had also 
emerged, to a lesser degree, in the Mid Atlantic and Northeast (Hunt & 
Truitt, 2006). 
 Street methamphetamine is referred to by many names, such as 
“speed,” “meth,” and “chalk.”  Methamphetamine hydrochloride, clear 
chunky crystals that resemble ice and can be inhaled by smoking, is 
referred to as “ice,” “crystal,” and “glass.”  The smoke from ice is 
odorless and leaves a residue that can be resmoked.  Producing effects 
that may continue for 12 or more hours, ice is a large, usually clear 
crystal of high purity that is most often smoked in a glass pipe (Hanson, 
2002; NIDA, 2006).   
Prevalence of Use 
 Second only to marijuana, methamphetamine is the most widely 
used illegal drug, with an estimated 35 million regular users worldwide 
(Rawson, Anglin, & Ling, 2002).  In fact, according to the Centers for 
Disease Control and Prevention (CDC; 2005), methamphetamine is 
considered the fastest-growing illicit drug in the United States. 
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Effects of Methamphetamine on Users 
 A synthetic psychostimulant, methamphetamine is a bitter-tasting 
crystalline powder that is white, odorless, and easily dissolvable in water 
or alcohol.  Methamphetamine is taken orally, intranasally (snorting), by 
smoking, or by needle injection (NIDA InfoFacts, 2008).  The effects of 
methamphetamine are produced in 3 to 20 minutes and, depending on 
method of use, remain present in the brain longer than other stimulants 
(from 6 to 24 hours).  Immediately after smoking or injecting, the user 
experiences an intense sensation called a “rush” or “flash” that lasts only 
a few seconds.  Oral or intranasal use produces euphoria, but not a rush.  
Like similar stimulants, methamphetamine is most often used in a “binge 
and crash” pattern.  As tolerance occurs within minutes, the intense 
pleasurable effects begin to disappear even before the concentration of 
the drug in the blood falls significantly.  This results in users trying to 
maintain the high by binging on the drug (Hanson, 2002; NIDA, 2006). 
 Methamphetamine releases high levels of the neurotransmitter 
dopamine, which stimulates brain cells and enhances mood and body 
movement.  It also damages brain cells that contain dopamine and 
serotonin (NIDA InfoFacts, 2008).  The effects of methamphetamine 
include increased activity, decreased appetite, euphoria, and elevated 
blood pressure – actions in the CNS that result from taking even small 
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amounts of the drug.  Other effects can include irritability, insomnia, 
confusion, anxiety, convulsions, tremors, paranoia, and aggressiveness.  
Users may become addicted quickly and use methamphetamine with 
increasing frequency and in increasing doses.  Methamphetamine can 
also cause irreversible damage to blood vessels in the brain, producing 
strokes, as well as increased heart rate, respiratory problems, 
cardiovascular collapse, and death (NIDA, 2006; NIDA InfoFacts, 2008). 
 In adults, high doses of methamphetamine not only cause 
adverse physiological effects, but also psychological and behavioral 
effects including violence, hostility, hallucinations, and paranoid 
psychosis that may resemble schizophrenia (Shearer, Sherman, Wodak, 
& vanBeek, 2002; Wouldes et al., 2004). 
 In a review on the neuropsychological effects of chronic 
methamphetamine use on neurotransmitters and cognition, Nordahl, 
Salo, & Leamon (2003) found that “neuroanatomical, neurochemical, and 
imaging data support the conclusion that methamphetamine abuse 
causes damage to multiple transmitter systems that are distributed 
throughout the brain.  Whether the ensuing damage is permanent or 
reversible over time has not yet been determined” (p. 320). 
 Finally, in a 2000 study, Ernst, Chang, Leonido-Lee, and Speck 
found that methamphetamine abuse causes harmful physical changes in 
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the brain that can last for many months, perhaps longer, after the drug 
use has stopped.  In the study, Drs. Chang and Ernst measured levels of 
brain chemicals that indicate whether brain cells are healthy, diseased, 
or damaged.  They found abnormal brain chemistry in the 
methamphetamine users in all three brain regions that were studied.  
Additionally, in one of the regions, the amount of damage was also 
related to the history of drug use.  Those who had used the most 
methamphetamine had the strongest indications of cell damage.  They 
concluded that methamphetamine was likely substantially toxic to the 
cells that humans use in thinking. 
Methamphetamine vs. Amphetamine: Differences, Similarities, and a 
Longitudinal Study 
 Methamphetamine’s chemical structure is similar to that of its 
parent drug, amphetamine; however, it has more pronounced effects on 
the CNS, specifically the sympathetic nervous system (Hanson, 2002; 
Smith et al., 2008).  Also described as the “first cousin” of amphetamine, 
methamphetamine has the addition of the methyl radical and exerts its 
action by releasing dopamine and serotonin, blocking monoamine 
reuptake mechanisms, and inhibiting monoamine oxidase (Lukas, 1997).  
In a recent article on animal studies, Goodwin et al. (2009) found that 
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both amphetamine and methamphetamine release excess dopamine into 
the dopaminergic neurons’ synaptic clefts. 
 The major difference appears to be in the mechanistic differences 
between methamphetamine- and amphetamine-mediated changes in 
DAT [dopamine transporter] activity, DA [dopamine] clearance in the 
nucleus accumbens, and DAT-mediated cellular responses (Goodwin et 
al., 2009).  Furthermore, these differences likely contribute to the greater 
euphoric and addictive properties of methamphetamine as the drug 
releases five times more dopamine, and twice as much from internal 
stores, when compared with amphetamine (Goodwin et al.). 
 The Swedish Longitudinal Study.  In the 1960s, short-term 
legalization of drugs of abuse occurred in Sweden.  Resulting 
populations of children who had been prenatally exposed to 
amphetamines were monitored in the years that followed.  In 1976-1977, 
65 newborns were selected for a study, due to their mothers’ addiction to 
amphetamine during pregnancy.  The cohort was followed prospectively 
until 14 years of age and compared to the normative population.  
Children in Groups 1 and 2 remained in their mothers’ custody at birth, 
while children in Group 3 were placed in foster-homes at birth.  Reports 
brought to light multiple prenatal complications resulting in the children’s 
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altered growth and behavior (Eriksson, Billing, Steneroth, & Zetterstrom, 
1985, 1989). 
 These studies, of virtually the same group of children as 
neonates, 4-year-olds, 8-year-olds, and 14-year-olds, showed that 
prenatal amphetamine exposure was correlated with poor social 
adjustment, as well as with increased aggressive behavior at 4 and 8 
years of age.  (Billing, Eriksson, Jonsson, Steneroth, & Zetterstrom, 
1994; Billing, Eriksson, Steneroth, & Zetterstrom, 1988; Eriksson, Billing, 
Steneroth, & Zetterstrom, 1989).  Behavior problems continued at age 14 
with a larger number of amphetamine-exposed children having a slightly 
lower IQ, being retained from grade advancement, and lagging behind in 
language, mathematics, and physical training when compared with 
unexposed controls (Billing, Eriksson, Steneroth, & Zetterstrom, 1985; 
Eriksson, Jonsson, Steneroth, & Zetterstrom, 2000; Eriksson & 
Zetterstrom, 1994).  Also significant was the finding that one-third of the 
children had social problems at age 14, irrespective of whether they were 
living with their biological mother or not.  In fact, by age eight, 44 of the 
65 children had been adopted or placed in foster homes (Eriksson, 
Jonsson, Steneroth, & Zetterstrom, 2000). 
 According to authors, another interesting finding was that after 8 
years of age, there appeared to be a difference in relation to the timing of 
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the amphetamine exposure.  Children in Group 1 (those who remained in 
mother’s custody at birth) that had been exposed to amphetamine only 
during the first trimester were less aggressive and performed better in 
some tests than did those in Group 2 (those who remained in mother’s 
custody at birth) and Group 3 (placed in foster care at birth) that had 
longer exposures.  However, the reasons for the more limited exposure 
in Group 1 are not known and may also have played an important role in 
these results.  Nevertheless, the authors suggest that their findings 
indicate that intrauterine exposure may cause prenatal damage that 
cannot be completely compensated by a good psychosocial environment 
after birth (Eriksson, Billing, Steneroth, & Zetterstrom, 1989). 
 Surprisingly, when the children were past puberty (14-years-old), 
gender differences were noted regarding their growth.  The 
amphetamine-exposed females were shorter and weighed less for their 
age, while the amphetamine-exposed males were taller and weighed 
more than the two Swedish standards that were used for comparison 
(Eriksson, Jonsson, Steneroth, & Zetterstrom, 2000; Plessinger, 1998).  
According to Plessinger, the findings seem to suggest that normal neural 
development and adenohypophysis maturation are affected by prenatal 
amphetamine exposure, with the onset of puberty being accelerated in 
boys but delayed in girls. 
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 A further finding of the Swedish study was that head 
circumference at birth and at 1 year of age was a significant predictor for 
level of achievement in Swedish language and school achievement for 
males at 14 years of age.  Additionally, head circumference at birth and 
at 1 year of age was a significant predictor for adjustment at 4 years and 
8 years of age for females (Eriksson, Jonsson, & Zetterstrom, 2000).  
These findings seem to correlate with earlier long-term follow-ups in 
which intrauterine drug exposure was shown to affect the head 
circumference of children, as well as studies finding a relationship 
between head size early in life and developmental scores in later life 
(Azuma & Chasnoff, 1993; Chasnoff, Burns, Burns, & Schnoll, 1986; 
Doberczak, Thornton, Bernstein, & Kandall, 1987; Hack et al., 1991; 
Lifschitz, Wilson, O’Brian-Smith, & Desmond, 1985). 
 Finally, Billing et al. (1994) and Eriksson and Zetterstrom (1994) 
found a significant correlation between exposure data, 
socioenvironmental factors, and behavioral characteristics.  They 
discussed that the confounding of these factors and the lack of a true 
control group would be definite limitations to their study.  It was 
discovered during the course of the longitudinal study that a greater 
proportion of the children with heavy amphetamine exposure were taken 
into custody early and placed into foster homes.  While approximately 
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80% left the hospital in their biological mothers’ custody, by 4 years of 
age, 50% were in foster homes, and by 10 years of age, 70% had been 
taken from their biological mothers and placed into foster care.  The most 
common reason was continuing abuse or failure of supportive measures 
(Billing et al; Eriksson & Zetterstrom). 
 Of the children who remained with their biological mothers, a high 
degree of social support was required and provided, with 75% receiving 
continuous economic support, 65% having a specially appointed contact 
person, and 30% being in drug treatment programs (Billing et al., 1994; 
Eriksson & Zetterstrom, 1994).  Moreover, authors found that of the 65 
children in the study, there were few reports of child abuse.  They 
suggest that this may be explained by the fact that these children had 
been surrounded by a protective social network since birth, which likely 
prevented some of the more serious postnatal environmental risk factors 
that would have had additional deleterious effects on the infants/children 
(Billing et al.). 
 Methamphetamine vs. Cocaine: Differences, Similarities, and a 
Longitudinal Study 
 Methamphetamine, amphetamine, and cocaine are all classified 
as psychostimulants.  While methamphetamine is structurally similar to 
amphetamine and the neurotransmitter dopamine, it is quite different 
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from cocaine.  While the stimulants behave similarly and have similar 
psychological effects on the body, the major differences of how each 
work happen at the nerve cell level.  Like cocaine, methamphetamine 
results in an accumulation of the neurotransmitter dopamine.  This 
excessive dopamine concentration produces the stimulation and feelings 
of euphoria.  However, while cocaine is quickly removed and almost 
completely metabolized in the body, methamphetamine has a much 
longer duration of action and a much larger percentage of the drug 
remains unchanged in the body.  The result is that methamphetamine is 
present longer in the brain and this ultimately leads to prolonged 
stimulant effects for the user (Hanson, 2002). 
 Nevertheless, studies have shown that prenatal exposure to 
cocaine is associated with premature birth and lower birth weight (Azuma 
& Chasnoff, 1993; Hulse, English, Milne, Holman, & Bower, 1997).  
Some reports also indicate that prenatal cocaine exposure is associated 
with deficits in cognitive and motor functioning in infants and children 
over the first two years of life (Arendt, Angelopoulos, Salvator, & Singer, 
1999; Singer et al., 1997).  However, there had not been large-scale 
reports of the longitudinal impact of prenatal cocaine exposure prior to 
the following study. 
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 The Maternal Lifestyle Study (MLS).  In the early 1990s, under the 
leadership of the National Institute of Child Health and Human 
Development (NICHD), planning began for a collaborative effort involving 
the NICHD, NIDA, Center for Substance Abuse Treatment (CSAT), and 
Administration on Children, Youth, and Families (ACYF).  This study, the 
Maternal Lifestyle Study (MLS), became a prospective report of the 
acute neonatal events and long-term developmental and health 
outcomes related to drug use during pregnancy (Smerglio & Wilcox, 
1999).  The MLS attempted to address earlier methodological 
challenges, including drug use detection, assessment of health and 
developmental status, small size, and measurements of potentially 
confounding factors (social class, quality of environment, continuing drug 
use, maternal mental health indicators).  Data collection began in 1993 at 
the four MLS sites (Detroit, Memphis, Miami, and Providence) and was 
designed to be a long-term follow-up of the children to age 7 (Smerglio & 
Wilcox). 
 In 2001, Lester et al. reported that the meconium specimens of 
8,527 newborns had been analyzed by immunoassay with gas 
chromatography/mass spectrometry (GC/MS) confirmation for 
metabolites of cocaine, opiates, cannabinoids, amphetamines, and 
phencyclidine.  This study highlighted the polydrug nature of what was 
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formerly thought of as a cocaine problem.  The prevalence of 
cocaine/opiate exposure in the four sites was 10.7% with the majority 
(9.5%) exposed to cocaine. 
 In 2002, Lester et al. looked at the effects of substance exposure 
during pregnancy on neurodevelopmental outcome in 1-month-old 
infants.  Still a part of the MLS, the sample consisted of 658 exposed and 
730 comparison infants matched on race, sex, and gestational age.  
Researchers found that the site of action for cocaine involves several 
areas of the brain that are thought to affect decision making, judgment, 
attention, planning, and mental flexibility (executive functions) in adults.  
Further, the authors suggest, the long-term implications are that the 
cognitive deficits likely caused by cocaine may not manifest until a child 
reaches school age (Lester et al.). 
 In 2003, using data from the MLS, Lester et al. examined a 
sample that included 477 exposed and 554 comparison infants matched 
for race, sex, and gestational age to study the effects of prenatal cocaine 
and/or opiate exposure on auditory brain response at one month.  They 
found that “…heavy cocaine exposure led to an increase in the I-III, I-V, 
and III-V interpeak latencies, indicating prolongation in neural 
transmission with heavy prenatal cocaine use during pregnancy” (p. 
284).  The I-V interpeak latency represents central brain stem conduction 
Multidimensional Functioning 
 26
time from the acoustic nerve to the inferior colliculus in the midbrain and 
is used as a measure of brainstem maturation, suggesting delayed 
maturation in the infants (Lester et al.). 
 In 2004, using data from the MLS, Messinger et al. evaluated the 
direct effects of prenatal cocaine exposure and opiate exposure on infant 
mental, motor, and behavioral outcomes between the ages of 1 and 3.  
The sample included 1,227 infants exposed to cocaine (n=474), opiates 
(n=50), cocaine and opiates (n=48), and neither substance (n=655) at 1, 
2, and 3 years of age.  Interestingly, the study found that infant prenatal 
exposure to cocaine and opiates was not associated with mental, motor, 
or behavioral deficits after controlling for birth weight and environmental 
risks.  Additionally, the direct impact that cocaine has on developing 
dopaminergic tissue is likely to depend on the timing and extent of 
exposure, with the effects becoming more evident as the more advanced 
motor, cognitive, language, and behavioral skills develop (Messinger et 
al.). 
 Given the effects that prenatal exposure to amphetamine and 
cocaine appears to have on infants and children, the fact that 
methamphetamine appears to have an even greater toxic effect on 
users, and that methamphetamine use is highest in the childbearing age 
group (18-25) (NIDA, 2006; Nordahl, Salo, & Leamon, 2003), it was 
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important to study the effects that the drug might have on the unborn.  
The logical place to start was with animal studies. 
Methamphetamine: Animals, Humans, and a Longitudinal Study 
  According to the NIDA (2008), more than 20 years of animal 
research shows that methamphetamine damages neuron cell-endings.  
In addition, although the neurons containing dopamine and serotonin do 
not die after methamphetamine use, their nerve endings are cut back 
and re-growth is limited.  Plessinger (1998) stated that clefting and optic 
defects have been demonstrated in mice and New Zealand White rabbits 
prenatally exposed to methamphetamine, along with ocular defects, 
herniated small intestines, malformed ribs and vertebrae, and 
exencephaly.  Interestingly, Plessinger also found that when male rabbits 
were treated with methamphetamine three months prior to mating, they 
sired offspring that were stillborn or suffered from various kidney defects 
and gastroschisis. 
In 2001, Won, Bubula, McCoy, and Heller discovered that 
maternal administration of methamphetamine in animals resulted in fetal 
brain drug concentrations that approximated amounts reported in human 
infants who were prenatally exposed to methamphetamine.  Slamberove, 
Pometlova, Syllabove, and Mancuskova (2005) stated that administration 
of methamphetamine to pregnant female rats during gestation resulted in 
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alarming, long-term impairment on the spatial learning of their adult 
offspring, while Arria et al. (2006) reported maternal and offspring 
mortality, retinal eye defects, cleft palate, rib malformations, decreased 
rate of physical growth, and delayed motor development in animals with 
prenatal methamphetamine exposure.  Finally, in a 2007 article, 
researchers found that rats from mothers exposed to methamphetamine 
during the prenatal period had impaired sensory-motor coordination 
(Slamberova, Pometlove, & Rokyta, 2007). 
 Few studies exist on the effects of prenatal methamphetamine 
exposure, and the existing literature is hampered by methodological 
shortcomings such as small sample size, difficulty establishing exposure 
status, confounding with other drugs, and environmental effects.  
Additional confusion is that some of the negative effects may be 
indirectly related to methamphetamine exposure.  For example, children 
who are born small-for-gestational-age (SGA) have an increased risk of 
developing type 2 diabetes and the metabolic syndrome later in life 
(Hales & Barker, 2001).  Moreover, decreased head circumference has 
been related to increased incidence of developmental problems in 
children (Smith et al., 2006).  In fact, although children with poor prenatal 
and postnatal head circumference have the worst neurodevelopmental 
outcomes, even children with small head circumference at birth, but with 
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good head growth postnatally, fare worse developmentally than control 
group children who are appropriate-for-gestation (Smith et al.). 
 The Infant Development, Environment, and Lifestyle Study 
(IDEAL).  The IDEAL study is an ongoing longitudinal study of the 
correlates and possible outcomes associated with prenatal 
methamphetamine exposure.  Clinical sites in specific geographic areas 
known to have methamphetamine problems were selected and include 
Tulsa, Los Angeles, De Moines, and Honolulu (Arria et al., 2006).  Out of 
a sample of 1,632 mothers (users and non-users of alcohol, tobacco, 
methamphetamine, and other drugs), 84 (5.2%) were classified as being 
methamphetamine exposed, meaning they had used methamphetamine 
at some point during their pregnancy.  Additionally, 2.8% were alcohol 
exposed, 25.3% were tobacco exposed, 6% were marijuana exposed, 
and 10.7% were any illicit drug exposed.  A final sample of 166 were 
enrolled in the longitudinal follow-up (n=74 exposed, n=92 matched 
comparison).  The method of enrollment ensured a community rather 
than a convenience or clinical sample of methamphetamine-using 
women with comparison subjects selected from the same hospital 
population.  Although amphetamine and ecstasy exposed mothers were 
also included in the methamphetamine group, less than 1% reported 
using these drugs during pregnancy (Smith et al., 2008). 
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 Early demographic findings in the IDEAL study revealed no 
differences in race between the methamphetamine-exposed and 
methamphetamine-unexposed groups (Smith et al., 2006).  The study 
also found that mothers in the methamphetamine-exposed group were 
more likely to have a lower social-position index, live in a household 
earning less than $10,000 per year, have public insurance, be without a 
partner, and be educated less than 12 years.  These mothers were also 
younger, sought prenatal care later in gestation, had fewer prenatal care 
visits, and gained more weight than the methamphetamine-unexposed 
group.  Additionally, tobacco, alcohol, and marijuana exposures were 
higher in the methamphetamine-exposed group.  Finally, 
methamphetamine-exposed neonates had lower birth weights and a 
higher incidence of SGA infants.  Length and head-circumference data 
was not available for the majority of unexposed neonates; therefore, 
there was limited ability to determine if growth restriction was symmetric 
or not (Arria et al., 2006). 
 In the first report from the prospective, matched comparison 
designed IDEAL study of children exposed to methamphetamine in-
utero, Smith et al. (2008) found that, although there were no differences 
in the one and five minute Apgar scores between the two groups, 
neurobehavioral patterns of increased physiological stress, and higher 
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amphetamine metabolite levels were associated with the 
methamphetamine-exposed group.  Additionally, results suggested that 
decreased arousal, physiological stress, and increased lethargy were 
associated with heavy methamphetamine exposure (Smith et al.). 
Methamphetamine: Additional Findings on Prenatal Exposure 
 Prenatal methamphetamine exposure, caregiving environment, 
and attachment security in 12- to 24- month-olds (infants).  In 1994, 
Lutsky conducted a study examining prenatal methamphetamine 
exposure, caregiving environment, and attachment security in 12- to 24-
month-old infants.  The study included 20 prenatally methamphetamine-
exposed children who had remained in their biological mother’s custody 
since birth (BIO group), 20 prenatally methamphetamine-exposed 
children who had been placed in foster custody continually for at least 
three months (FOSTER group), and 20 children who had not been 
prenatally exposed to drugs or alcohol and who had been in their 
biological mother’s custody since birth (CONTROL group).  Findings 
were that 50 of the 60 children had secure attachments, although there 
were a significantly greater number of insecure/disorganized 
attachments among the drug-exposed BIO group versus the non-drug 
exposed CONTROL group.  Additionally, caregiving environment 
seemed to be unrelated to the quality of attachment among the children 
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prenatally exposed to methamphetamine as the incidence of 
insecure/disorganized attachments did not significantly differ between 
the BIO and FOSTER groups (Lutsky). 
 Fetal and infant deaths associated with maternal 
methamphetamine abuse.  Stewart and Meeker (1997) studied eight 
cases of fetal and infant death that were related to maternal 
methamphetamine abuse.  The cause for death in each case was 
abstracted from the information supplied by pathologists’ reports.  On 
average, fetal death occurred at gestation week 30 with a range of 20 to 
36 weeks.  Fetuses were from five to eight months in maturation, with 
two newborns being full term.  They found that the fetus was at greatest 
risk during the first trimester of the pregnancy, the time when cells 
differentiate and develop into limbs and organs, while the risk of 
spontaneous abortion in the second trimester, and risk of premature birth 
in the third trimester were also increased with drug use.  The brain and 
nervous system develop throughout pregnancy and were ultimately 
always vulnerable to damage. 
 Because methamphetamine also increases heart rate, constriction 
of the blood vessels, and blood pressure elevation, the mothers were at 
risk for premature separation of the placenta from the uterine wall, which 
results in spontaneous abortion or premature delivery.  Stewart and 
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Meeker (1997) reported considerable placental transfer of 
methamphetamine from maternal to fetal blood because of the drug’s low 
molecular weight and lipid solubility.  With this transfer and the 
immaturity of fetal metabolic abilities, the methamphetamine remained in 
the fetus’ circulatory system much longer than it remained in the 
mother’s blood.  Therefore, fetal stroke was also a risk as 
methamphetamine causes acutely elevated blood pressure in the fetus.  
According to the authors, “Mechanisms by which methamphetamine can 
compromise fetal development include fetal acidosis, hypoxernia, 
decreased uterine blood flow, changes in fetal blood gases, and an 
increase in fetal glucose levels” (Stewart & Meeker, p. 517). 
 Brain proton magnetic resonance spectroscopy in children 
exposed to methamphetamine in utero.  In 2001, Smith et al. found 
evidence for in vivo brain metabolite alterations in children who were 
prenatally exposed to methamphetamine.  Furthermore, these children 
had increased creatine [Cr] in their basal ganglia but without significant 
differences in NA [N-acetylaspartate], which is a biochemical marker of 
neural loss.  These findings suggested an abnormality in energy 
metabolism in the brains of children prenatally exposed to 
methamphetamine.  Interestingly, no differences were found in reported 
behavior problems among the methamphetamine-exposed children 
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relative to the unexposed group.  This was surprising as, according to 
authors, “The scant developmental data available on methamphetamine-
exposed children suggest they have disorders of executive function 
manifested by aggressive behavior and hyperactivity” (Smith et al., p. 
258). 
 Effects of prenatal methamphetamine exposure on fetal growth 
and drug withdrawal symptoms in infants born at term.  In a study of the 
effects of prenatal methamphetamine exposure on fetal growth and drug 
withdrawal symptoms in infants born at term, Smith et al. (2003) 
retrospectively identified 134 neonates whose mothers used 
methamphetamine during pregnancy and matched them to 160 
unexposed newborns.  Results indicated no differences in infant growth 
parameters, but found that methamphetamine exposure was associated 
with decreased growth relative to infants exposed only for the first two 
trimesters.  Additionally, significantly more SGA infants were found in the 
methamphetamine-exposed group.  Withdrawal symptoms requiring 
pharmacologic intervention were observed in 4% of the 
methamphetamine-exposed infants.  Furthermore, methamphetamine 
use during all three trimesters was associated with lower birth weight and 
head circumference.  The authors also stated that their findings were 
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consistent with other studies in which growth parameters at birth were 
not affected by adequate prenatal care (Smith et al., 2003). 
 Methamphetamine abuse during pregnancy and its health impact 
on neonates born at Siriraj Hospital, Bangkok, Thailand.  In 2004, 
Chomchai et al. studied the impact of intrauterine methamphetamine 
exposure on the overall health of newborn infants using a sample of 47 
infants born to methamphetamine abusing mothers and 49 newborns 
whose mothers did not use methamphetamine during pregnancy.  They 
found that the methamphetamine-exposed group had a significantly 
smaller gestational age-adjusted head circumference and birth weight.  
Additionally, methamphetamine exposure was also associated with 
symptoms of agitation, vomiting, and tachypnea when compared to the 
nonexposed group.  Finally, the authors discuss prior research 
suggesting that methamphetamine exposure during fetal life can produce 
problems with behavior, learning, and cognition; results that are 
sustained through utero-placeptal insufficiency, intracranial 
hemorrhages, and smaller overall growth (Chomchai et al., 2004). 
 Smaller subcortical volumes and cognitive deficits in children with 
prenatal methamphetamine exposure.  Chang et al. (2004) studied 
children between the ages of 3 to 16 with a history of methamphetamine 
exposure in-utero to examine the possible neurotoxic effects of prenatal 
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methamphetamine exposure on the developing brain and cognition.  
Using magnetic resonance imagery (MRI) and various 
neuropsychological measures on a sample of 13 methamphetamine-
exposed children and 15 unexposed children, the authors found that 
methamphetamine-exposed children scored lower on measures of visual 
motor integration, attention, long-term spatial memory, and verbal 
memory.  Additionally, compared with the control group, children 
prenatally exposed to methamphetamine exhibited smaller subcortical 
volumes and associated neurocognitive deficits.  While they found no 
difference in motor skills, short delay spatial memory, or measures of 
non-verbal intelligence, the researchers correlated the deficiencies in the 
brain structures with poor performances on measures of sustained 
attention and delayed verbal memory.  Their conclusion was that 
prenatal methamphetamine exposure “…may be neurotoxic to the 
developing brain” (Chang et al., 2004, p. 95). 
 Cognitive development in methamphetamine exposed and high-
risk infants.  In a 2006 dissertation, Vaz examined the cognitive 
development in methamphetamine-exposed and high-risk infants.  The 
study utilized retrospective data collected from a state-funded grant 
program.  To investigate the effects of prenatal methamphetamine use 
on cognitive development, the author used the Bayley Scales of Infant 
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Development (BSID) and the Parenting Stress Index (PSI) scores of 34 
mother/child dyads.  According to the author, the findings suggested that 
the mothers’ educational attainment and enhanced social and emotional 
support had potentially protective effects on the attachment quality and 
cognitive development of high-risk and drug-exposed infants (Vaz). 
 Structural and metabolic brain changes in the striatum associated 
with methamphetamine abuse.  In 2007, Chang, Alicata, Ernst, and 
Yolkow used MRI and positron emission tomography (PET) scans to 
evaluate brain structural, chemical, and metabolite changes in 
methamphetamine subjects and children with prenatal 
methamphetamine exposure.  They found that the children with 
methamphetamine exposure showed smaller striatal structures and 
elevated total creatine.  Additionally, reduced dopamine transporter 
[DAT] density and reduced dopamine D2 receptors in the striatum were 
consistently shown in the PET scans.  The authors suggest that 
neuroimaging studies convincingly demonstrate that individuals who use 
methamphetamine, as well as children with prenatal methamphetamine 
exposure, have abnormalities in brain structure and chemistry, 
particularly in the striatum (Chang et al.). 
 Ian: A 7-year-old with prenatal drug exposure and early exposure 
to family violence.  A 2008 case study by Stein, Drahota, and Chavira 
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revealed physical aggression, attention and focusing difficulties, and 
repetitive and phobic behaviors in a 7-year-old male who had been 
exposed to methamphetamine and marijuana throughout gestation.  He 
was also diagnosed with a receptive and expressive language disorder 
at age 4 years.  Moreover, a Gilliam Autism Rating Scale indicated the 
probability of autism.  A Wechsler Intelligence Scale-IV revealed that Ian 
had a verbal intelligence quotient of 75 and a performance intelligence 
quotient of 108, with a full scale score of 81.  Although he was born by 
Caesarean section, due to failure to progress, he received normal Apgar 
scores and followed an unremarkable neonatal course (Stein, Drahota, & 
Chavira, 2008). 
 Prenatal exposure to methamphetamine presenting as neonatal 
cholestasis.  Finally, a 2009 study by Dashan revealed neonatal 
cholestasis related to prenatal exposure to methamphetamine in a 35 
week preterm, appropriate for gestational age female.  Cholestatic 
hepatitis is a recognized complication of exposure to specific drugs 
(carbamazepine and trimethoprim-sulfamethoxazole); however, 
according to the author, this case was the first recorded of neonatal 
cholestasis related to prenatal methamphetamine exposure (Dashan, 
2009). 
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Alcohol: Effects of Prenatal Exposure 
 Although the focus of this study will be on the overarching effects 
of prenatal methamphetamine, it is important to also recognize another 
substance, alcohol, whose prenatal exposure has been found to have 
extremely detrimental effects on infants and children.  Studies examining 
the effects of prenatal alcohol exposure on infants have been numerous.  
Alcohol use during pregnancy has been found to contribute to effects in 
exposed children ranging from hyperactivity/attention problems, 
learning/memory deficits, to problems with social/emotional development 
(Jacobson & Jacobson, 2002).  While the most serious consequences of 
prenatal alcohol exposure is “fetal alcohol syndrome” (FAS), the term 
"fetal alcohol effects" (FAE) is used for children whose mothers drank 
heavily during pregnancy, but who exhibit only some of the 
characteristics of FAS. Additionally, "alcohol-related neurodevelopmental 
disorder" (ARND) has been used to describe children whose mothers 
had confirmed heavy prenatal alcohol exposure and who exhibit 
measurable, but subtler, neurobehavioral deficits than individuals with 
FAS (Jacobson & Jacobson).  A 2002 study conducted by Jacobson and 
Jacobson found that although the most severe patterns of 
intellectual/cognitive deficits (hyperactivity, sustained attention, cognitive 
flexibility, planning abilities, learning, memory, and socioemotional 
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functioning) are typically found in children with FAS, children who have 
been prenatally exposed to much lower levels of alcohol frequently 
exhibit similar problems.  Likewise, in an earlier study exploring the long-
term outcome of children with FAS, psychopathology, behavior, and 
intelligence assessments were conducted on children from preschool 
age to late school age (greater than 13 years of age).  Findings included 
a strong persistence over time of excessive psychopathology.  
Symptoms included hyperkinetic disorders, emotional disorders, sleep 
disorders, and abnormal habits and stereotypes.  Further, cognitive 
functioning was marked by a large proportion of mentally retarded 
children.  The long-term outcome study reflected the severe 
handicapping effects of FAS (Steinhausen & Spohr, 1998). 
 In a more recent study evaluating the social problem solving skills 
of adolescents with histories of fetal alcohol exposure, researchers found 
that alcohol-exposed adolescents had substantial impairments, even in 
the absence of mental retardation, in their abilities to solve problems in 
everyday life.  These impairments were also likely to have a significant 
impact on social and academic functioning (McGee, Fryer, Bjorkquist, 
Mattson, & Riley, 2008).  Finally, in a 2009 study, the language abilities 
of children (ages 3 to 5) with heavy prenatal alcohol exposure were 
evaluated.  Results indicated that the alcohol exposed group had 
Multidimensional Functioning 
 41
significantly poorer language skills than did a control group.  However, 
the language performance did not deviate significantly from what would 
be predicted by full scale IQ scores for either group.  The authors 
suggested that while receptive and expressive language abilities are 
impaired in children with heavy prenatal alcohol exposure, they are not 
more impaired than the children’s general intellectual functioning.  They 
further posited that the deficits are likely to impact the social interactions 
and behavioral adjustments of children with prenatal alcohol exposure 
(McGee, Bjorkquist, Riley, & Mattson, 2009). 
Marijuana: Effects of Prenatal Exposure 
 Finally, as marijuana is one of the most commonly used drugs by 
pregnant women, Karila, Cazas, Danel, & Reynaud reviewed the 
literature in 2006 to examine the association between cannabis use 
during pregnancy and the resulting effects upon growth, cognitive 
development, and behavior of newborns, children and teenagers.  They 
found that cannabis use during pregnancy was related to diverse 
neurobehavioral and cognitive outcomes, including symptoms of 
inattention, impulsivity, deficits in learning and memory, and a deficiency 
in aspects of executive functions.  In conclusion, in a 2008 prospective 
study of the effects of prenatal marijuana exposure on the intelligence 
test performance of children, Goldschmidt, Richardson, Willford, & Day 
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found a significant nonlinear relationship between marijuana exposure 
and child intelligence.  Heavy marijuana use (one or more cigarettes per 
day) during the first trimester was associated with lower verbal reasoning 
scores, while heavy use during the second trimester predicted deficits in 
composite, short-term memory, and quantitative scores.  Additionally, 
heavy use during the third-trimester was negatively associated with the 
quantitative score.  The authors concluded that prenatal marijuana 
exposure has a significant effect on school-age intellectual development 
(Goldschmidt, Richardson, Willford, & Day, 2008). 
Limitations and Confounding Variables in Previous Studies 
 Human studies examining the effects of methamphetamine use on 
the developing fetus have been limited by small sample sizes with 20 
participants or less (Chang et al., 2004; Smith et al., 2001).  Additionally, 
limitations have included reliance on maternal self-report for confirmation 
of drug use, multidrug abuse, and comparisons with normative peer 
samples, rather than control groups (Wouldes et al., 2004).  Moreover, a 
major difficulty lies in distinguishing between the negative impact of 
methamphetamine exposure in-utero and the exposure that occurs 
postnatally through home manufacture or chronic maternal use of the 
substance (McGuinness & Pollack, 2008).  Furthermore, difficulty lies in 
the potential confounding effects of mothers’ educational attainment, as 
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well as emotional and social support (Vaz, 2006).  Finally, while 
methamphetamine has been a significant drug problem since the 1990s, 
studies investigating the long-term effects of prenatal exposure to the 
drug are sparse, while the numbers of exposed infants appears to be 
rising.  For example, the facility in this study noted a startling increase in 
the numbers of very young children (under the age of 2½ years) 
presenting with prenatal methamphetamine exposure: from 155 between 
the years of 1997 through 2007; to 89 over the past year and two 
months.  Although the IDEAL study is now following children with 
prenatal methamphetamine exposure, the investigators are still in the 
beginning stages of collecting data on these subjects (Smith, et al., 
2008). 
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Chapter 3 
Method 
Overview 
 This study analyzed retrospective data collected from an 
outpatient facility that conducts multidisciplinary developmental 
evaluations of children from 1 month to 7 years of age with prenatal 
exposure to alcohol and/or drugs.  The facility is part of a state-funded 
university health complex located in a large Southwestern city.  The 
program is funded by a grant from the Oklahoma Department of Mental 
Health and Substance Abuse Services (ODMHSAS), and offers services 
provided by psychologists, social workers, and interdisciplinary staff, 
including a physical therapist and developmental pediatrician. 
 Demographic information, as well as measures of cognitive, 
language, motor, emotional and behavioral functioning, and physical 
indicators of development were completed on each infant and child and 
entered into a database.  Positive prenatal drug exposure was 
determined by mother self-report, caregiver-report, and/or a positive 
toxicology screening at the time of the child’s birth. 
Participants 
 The program in this study provides a model for early identification 
and intervention of fetal alcohol and drug exposed infants and toddlers.  
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As the only program in the state specifically designed to work with infants 
and children with prenatal exposure to drugs and/or alcohol and their 
families, referrals come to this program from across the state.  There 
were 1,556 records in the program’s database of children between the 
ages of 1 month to 7 years, for the time period of April 23, 1997 through 
June 15, 2009, who were administered the Bayley Scales of Infant 
Development – Second Edition (BSID-II; Bayley, 1993), Bayley Scales of 
Infant Development – Third Edition (BSID-III; Bayley, 2006), Wechsler 
Preschool and Primary Scales of Intelligence – Revised Edition (WPPSI-
R; Wechsler, 1989), and Wechsler Preschool and Primary Scales of 
Intelligence – Third Edition (WPPSI-III; Wechsler, 2002).  However, 
many of the children were assessed multiple times and at different ages.  
Therefore, while a child may have been included in more than one 
measurement grouping in the current study (e.g., completed the BSID-II 
at age 12 months; completed the WPPSI at a return visit at age 36 
months; scores at each visit will be included in the study), each child was 
only included in a measurement grouping one time (e.g., completed the 
BSID-II at 6 months; completed the BSID-II again at a return visit at age 
12 months; only scores for one of the visits will be included in the study). 
 Participants were grouped according to reported prenatal 
substance exposure.  Group 1 included children who were prenatally 
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exposed to methamphetamine only; Group 2 included children who were 
prenatally exposed to methamphetamine plus other substances; and 
Group 3 included children who were prenatally exposed to other 
substances not including methamphetamine.  A caveat to the Group 1 
description was that several of these children’s prenatal exposure also 
included nicotine.  According to a 2008 unpublished manuscript by 
Gurwitch, et al. that analyzed patients from the same clinic as in this 
study, no significant differences were observed between a group of 
methamphetamine-only exposed children and a group of 
methamphetamine plus nicotine exposed children in terms of cognitive, 
language, or behavioral variables.  The only area in which a significant 
difference was found included motor scores.  Specifically, children in the 
methamphetamine-only group performed significantly lower than children 
in the methamphetamine and nicotine group (Gurwitch, Mignogna, 
Wagener, & Wolfe-Christensen, 2008). 
 Fifteen hundred and fifty-six child records were included in this 
study.  However, because of missing data, not all records were included 
in all analyses. 
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Measures 
 Demographic information was obtained using clinic intake forms.  
Depending upon the child’s age and the year of administration, cognitive 
development was assessed using the Bayley Scales of Infant and 
Toddler Development – Second Edition, Mental Developmental Index  
(BSID-II, MDI; Bayley, 1993), Bayley Scales of Infant and Toddler 
Development – Third Edition, Mental Scale (BSID-III; Bayley, 2006), the 
Wechsler Preschool and Primary Scales of Intelligence-Revised 
(WPPSI-R; Wechsler, 1989), or Wechsler Preschool and Primary Scales 
of Intelligence, Third Edition (WPPSI-III; Wechsler, 2002).  Language 
development was assessed using the BSID-II, MDI, (Bayley, 1993), 
BSID-III Language Scale (Bayley, 2006), the Preschool Language Scale, 
Third Edition (PLS-3; Zimmerman, Steiner, & Pond, 1992) or Preschool 
Language Scale, Fourth Edition (PLS-4; (Zimmerman, Steiner, & Pond, 
2008) depending upon the child’s age and the year of administration.  
Motor development was assessed using the BSID-II, Psychomotor 
Developmental Index (BSID-II, PDI; Bayley, 1993), BSID-III Motor Scale 
(Bayley, 2006), or the Peabody Developmental Motor Scales, Second 
Edition (PDMS-2; Folio & Fewell, 1983) depending upon the child’s age.  
Emotional functioning was assessed using the Behavior Assessment 
System for Children, Parent Rating Scale (BASC-PRS; Reynolds & 
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Kamphaus, 1992) or Child Behavior Checklist (CBCL; Achenbach, 
1991), and behavioral functioning was assessed using the Eyberg Child 
Behavior Inventory (ECBI; Eyberg & Pincus, 1999).  Head circumference 
was obtained using medical forms and/or the Child Health Screening 
Physical Indicators of Development form (PID). 
 Demographics.  A clinic intake form was used to collect the 
infant/child and family information.  Often, these children do not reside 
with their biological mother or father; therefore, the information regarding 
the biological parents and developmental history of the child is obtained 
from the current caregiver (i.e., foster parent, adoptive parent, or case 
worker).  These individuals are generally knowledgeable about the 
child’s history from personal experience or from Oklahoma Department 
of Human Services (OKDHS) records. 
 Information was gathered during an intake interview conducted 
with the child’s caregiver(s) by a clinic professional at the time of the 
child’s assessment visit.  In the current study, the child’s age, sex, 
ethnicity/race, birth prematurity, and prenatal substance exposure was 
extracted for descriptive purposes.  Additionally, extracted information 
included the number of primary caregiver changes, length of time with 
current caregiver, primary caregiver relationship, primary caregiver 
socioeconomic status, biological parents’ ethnicities/races, biological 
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parents’ dates of birth, biological parents’ education levels, and biological 
parents’ marital status.  Finally, to aid in developing as complete a 
picture as possible of these children, previous and current levels of 
Department of Human Services (DHS) involvement, abuse and neglect 
charges, domestic violence charges, prenatal care, number of 
pregnancies, number of children, and number of children residing with 
biological mother was also included. 
 BSID-II and BSID-III.  The Bayley Scales of Infant Development 
(BSID) was developed by Nancy Bayley in 1969 and was a derivative of 
several theoretically eclectic scales of infant development (Bayley, 
2006).  The 2006 BSID Third Edition (BSID-III) is the revised edition of 
the 1993 BSID Second Edition (BSID-II); both instruments are utilized to 
measure development in infants aged 1 month to 42 months, as well as 
to diagnose developmental delays and to plan intervention strategies.  
Composite raw scores are converted to standardized scores (M=100, 
SD=15) for ease of comparison with other measures and between 
subjects (Bayley, 2006). 
 While the BSID-II consisted of a Mental Developmental Index 
(MDI; which assesses current cognitive and language functioning), a 
Psychomotor Developmental Index (PDI; which evaluates fine and gross 
motor functioning), and a Behavior Rating Scale score (BRS; which 
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assesses the qualitative aspects of test-taking behavior), only the MDI 
and PDI scores of the BSID-II will be utilized in this study.  The MDI was 
used as a measure of cognitive and language functioning, as it evaluates 
sensory-perceptual abilities, object permanence skills, memory, learning, 
verbal communication, and abstract thinking skills.  The PDI was used as 
a measure of motor functioning, as it evaluates gross and fine motor 
skills and overall body control. 
 The creation of a separate Language Scale in the BSID-III not 
only reduced the number of items within the BSID-II Mental Scale, it also 
permitted expansion of the cognitive concepts and constructs being 
assessed within the BSID-III Cognitive Scale.  Additionally, the separate 
Language Scale made it possible to measure receptive and expressive 
language skills, two areas that require different abilities and that can 
develop independently.  The ability to assess these separately is 
important when diagnosing critical delays and in determining the etiology 
of the delay (Bayley, 2006).  The BSID III is comprised of five scales 
designed to assess young children’s developmental functioning across 
the Cognitive, Language (receptive and expressive), Motor (fine and 
gross), Social-Emotional, and Adaptive (conceptual, social, and practical) 
behavior domains.  The Cognitive, Language, and Motor portions of the 
BSID-III are completed by professionals, while the Social-Emotional and 
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Adaptive portions are assessed using questionnaires completed by the 
child’s caregiver (Bayley, 1993, 2006).  The facility in this study utilizes 
only the Cognitive, Language, and Motor portions of the BSID-III; 
therefore, these were the three domains of the BSID evaluated in this 
paper. 
 According to Tobin and Hoff (2004), the BSID-III maintained the 
objectives and general assessment approach of its predecessors while 
improving the psychometric properties.  In general, the psychometric 
properties of the Bayley-III far exceed the guidelines recommended by 
the American Educational Research Association, American 
Psychological Association, and National Council on Measurement in 
Education.  Reliability coefficients for the Bayley-III composites are 
presented by age group with the average reliability coefficients 
calculated using Fisher’s z transformation (Silver & Dunlap, 1987; 
Strube, 1988).  The average reliability coefficients for the Cognitive, 
Language, and Motor composite scores were .91, .93, and .92, 
respectively, with the highest subtest being .98 and the lowest subtest 
being .71.  The majority of the subtest reliability coefficients across 
special groups are similar to or higher than those coefficients reported for 
the normative sample, which suggests that the Bayley-III is an equally 
reliable tool for the assessment of children with clinical diagnoses, as 
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well as children from the general population (Bayley, 2006).  Test-retest 
reliability was estimated using Pearson’s product-moment correlation 
coefficient, with Cohen’s d used to report standard differences (Cohen, 
1996).  Bayley-III scores possess a high degree of stability over time and 
show a slight increase in stability across age groups.  The data show an 
increase between the first and second testing of approximately .3 points 
in the Receptive and Expressive Communication subtests and .9 points 
in the Cognitive Scale across all ages.  Additionally, the data show an 
increase of 2.1 points on the Language composite and 3.5 points on the 
Motor composite (Bayley, 2006). 
 In validity studies, Bayley–III composite and subtest standard 
scores met theoretical expectations and were consistent with the results 
of the WPPSI–III, the PLS–4, and the Peabody Developmental Motor 
Scales, Second Edition (PDMS–2; Folio & Fewell, 2000).  The BSID-III 
Cognitive Scale correlates highly with the WPPSI-III FSIQ (r = .79), yet 
seems more related to the VIQ (r = .79) than the PIQ (r = .72).  
Regarding language, the data show very little difference between the 
means of the Bayley-III composites and the PLS-4 scores.  The highest 
correlation was between the Bayley-III Language composite and the 
PLS-4 Expressive Communication subtest (r = .71).  The pattern of 
correlations and lack of difference between the means suggest that the 
Multidimensional Functioning 
 53
Bayley-III Language Scale and the PLS-4 assess similar constructs.  
Finally, regarding motor, the data show very little difference between the 
means of the Bayley-III composites and the PDMS-2 quotients.  The 
highest correlations were between the BSID-III Fine Motor subtest and 
the PDMS-2 Fine Motor Quotient (r = .59), and between the BSID-III 
Gross Motor subtest and the PDMS-2 Gross Motor Quotient (r = .57).  A 
moderate correlation is also seen between the BSID-III Motor composite 
and the PDMS-2 Total Motor Quotient (r = .55).  Evidence has also been 
provided to show that the Bayley-III is sensitive to performance 
differences between children in the normative sample and samples of 
children with various conditions placing them at risk for developmental 
delay (Bayley, 2006). 
 WPPSI-R and WPPSI-III.  The Wechsler Preschool and Primary 
Scales of Intelligence (WPPSI) is a standardized test designed to 
measure intelligence in children between the ages of 2 years, 6 months 
{Record Form Ages 2:6-3:11} and 7 years, 3 months of age {Record 
Form Ages 4:0-7:3}.  The 2002 WPPSI Third Edition (WPPSI-III) is the 
revised edition of the 1989 WPPSI Revised Edition (WPPSI-R).  Both 
versions of the WPPSI contain two core batteries in which subtests yield 
a Verbal IQ (VIQ) and a Performance IQ (PIQ).  When combined, the two 
scales produce a Full Scale IQ (FSIQ).  The VIQ is a measure of verbal 
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ability, including assessment of word knowledge, ability to acquire, 
retain, and retrieve general factual knowledge, analogic and general 
reasoning ability, and ability to integrate and synthesize different types of 
information.  The PIQ is a measure of nonverbal ability, including 
perceptual recognition and discrimination, spatial analysis, abstract 
visual problem solving, and visual-motor coordination (Wechsler, 1989, 
2002). 
 The WPPSI-R contains 12 subtests, while the WPPSI-III includes 
14 subtests.  In both versions, the child’s general intellectual functioning 
is represented using an FSIQ with a mean of 100 and standard deviation 
of 15.  The same metric is employed for all composites as raw scores on 
each subtest are converted to scaled scores with a mean of 10 and 
standard deviation of 3.  The scaled scores were used to calculate the 
VIQ and PIQ (Wechsler, 1989, 2002).  In the current study, only the core 
tests were utilized and the FSIQ reported. 
 The WPPSI-R and WPPSI-III have been shown to have high 
concurrent validity at .70 for the Performance Scale, .86 for the Verbal 
Scale, and .85 for the Full Scale IQ.  They also produced split-half 
reliability estimates of .83 to .95, with only a few subtests being less than 
.80 at specific ages.  The average Full Scale internal consistency 
coefficient was high at .96 (Wechsler, 2002).  In the current study, use of 
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the specific version of the WPPSI depended upon the child’s age and the 
year of the evaluation. 
 PLS-3 and PLS-4:  The Preschool Language Scale (PLS) was 
developed by Irla Lee Zimmerman, Ph.D.; Violette G. Steiner, B.S.; and 
Roberta Evatt Pond, M.A.  The measure was designed to be individually 
administered by professionals to identify language disorders or delays in 
children, birth through 6 years, 11 months of age.  A revision of the 1992 
PLS Third Edition (PLS-3), the 2008 PLS Fourth Edition (PLS-4) features 
expanded language coverage and updated norms. 
 The PLS yields receptive and expressive subtest scores, which 
combine to form a Total Language Composite score.  Language skills 
are targeted in the areas of language structure, vocabulary, phonological 
awareness, vocal development, social communication, integrative 
language skills, gesture, concepts, attention, and play.  The Auditory 
Comprehension score is comprised of 62 items (each correct answer 
earns one point) and measures the ability to understand words and their 
relationships (i.e., receptive language).  The Expressive Communication 
score is comprised of 68 items (each correct answer earns one point) 
and measures the ability to use words and sentences to express ideas, 
wants, and needs.  Each of the scores, Auditory Comprehension, 
Expressive Communication, and Total Language Score, is standardized 
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with a mean of 100 and a standard deviation of 15 (Zimmerman, Steiner, 
& Pond, 1992, 2008). 
 On the PLS-3, concurrent validity for Auditory Comprehension 
was .69, for Expressive Communication was .75, and for Total Language 
was .82.  Internal consistency reliability ranged from .47 to .86 for 
Auditory Comprehension, from .68 to .86 for Expressive Communication, 
and from .74 to .92 for the Total Language Score.  Interrater reliability 
was .98 (Zimmerman et al., 1992). 
 On the PLS-4, extensive evidence of validity based on test 
content, response processes, internal structure, relationships with other 
variables, and consequences of testing has been reported.  A clinical 
validity study was conducted with a sample of 150 children (75 with a 
language disorder, 75 typically developing children). Sensitivity and 
specificity information for PLS-4 scores for children in this study were: 
Auditory Comprehension sensitivity .80, specificity .92; Expressive 
Communication sensitivity .77, specificity .84; and Total Language Score 
sensitivity .80, specificity .88.  Test-retest reliability coefficients ranged 
between .82 and .95 for subscale scores and .90 to .97 for Total 
Language Score.  Internal consistency reliability coefficients range from 
.66 to .96 with coefficients of .81 and higher for most ages.  Inter-rater 
reliability was scored with an agreement percentage of 99% 
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(Zimmerman, Steiner, & Pond, 2008).  In the current study, use of the 
specific version of the PLS depended upon the year of the child’s 
evaluation. 
 PDMS-2.  The Peabody Developmental Motor Scales Second 
Edition (PDMS-2) was developed by M. Rhonda Folio and Rebecca R. 
Fewell.  An early childhood motor development program that provides 
both in-depth assessment and training or remediation of gross and fine 
motor skills, the assessment was designed to be used in settings that 
provide services to preschool age children from birth through 5 years of 
age.  The PDMS-2 is composed of two primary scales (Gross Motor and 
Fine Motor), six subtests (Reflexes, Stationary, Locomotion, Object 
Manipulation, Grasping, and Visual-Motor), and 72 items (the score for 
each item ranges from 0 to 2).  The Gross Motor development score and 
Fine Motor development score yield a Total Motor Quotient that is a 
measure of the interrelated motor abilities that develop early in life.  The 
subtests within the domains of Gross Motor and Fine Motor yield scores 
with a mean of 10 and a standard deviation of 3.  Scores are presented 
as percentiles, standard scores, and age equivalents, with norms that 
are stratified by age and based on a nationally representative sample of 
more than 2,000 children (Folio & Fewell, 1983).  In the present study, 
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the standardized scores will be utilized for ease of comparison with other 
measures and between subjects. 
 Concurrent validity evidence for the PDMS-2 and the BSID had 
high correlations for the Fine Motor scales (r = .87) and the Gross Motor 
scales (r = .83).  Criterion-prediction validity measured (r = .80) in 
comparisons with the first edition of the PDMS, as well as with another 
comparable test (Bunker, 2000).  According to Anastasi and Urbina 
(1997), overall reliability is based on three sources of test error (content, 
time, and scorer) and showed a high degree of consistency.  The Fine 
Motor coefficients were content sampling (r = .96), time sampling (r = 
.93), and interscorer differences (r = .98).  Gross Motor coefficients were 
content sampling (r = .96), time sampling (r = .89), and interscorer 
differences (r = .97). 
 BASC-PRS.  The Behavior Assessment System for Children 
(BASC) was developed by Cecil R. Reynolds, Ph.D. and R.W. 
Kamphaus, Ph.D. in 1992.  A multimethod, multidimensional system 
intended to assess observable behavior and self-perception ratings of 
individuals ages 2-25, the BASC self-report forms contain items that tap 
multiple emotional and behavioral domains and are completed by the 
parent, teacher, and child.  Producing scaled scores that represent 
pathological and adaptive characteristics as quantitative deviations from 
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the mean (Doyle et al., 1997), the data included in this study were based 
only on the parent self-report forms for ages 2 years, 6 months through 5 
years (PRS-P, 131 items) and ages 6 years through 11 years (PRS-C, 
138 items). 
 The BASC Parent Rating Scale (BASC-PRS) is completed by a 
parent, guardian, foster parent or other custodial caregiver with regard to 
a child's adaptive and problem behaviors in the home and community 
settings.  Assessing adaptive and problem behaviors, the PRS scale is 
completed using a four-choice response format, ranging from Never (0) 
to Almost Always (3).  The PRS yields T-scores in broad internalizing 
and externalizing domains, as well as in specific content areas (Doyle et 
al., 1997).  The Clinical Scales include Hyperactivity, Aggression, 
Anxiety, Depression, Somatization, Atypicality, Withdrawal, and Attention 
Problems, while the Adaptive Scales include Adaptability and Social 
Skills.  Internal consistency of the various BASC-2 forms is relatively high 
(Doyle et al.). 
 According to Hughes and Melson (2008), validity of the BASC-2 
measures appear to be high with evaluations largely focused on the 
instrument’s correlation with other assessment scales.  Regarding 
predictive validity, children in clinical samples demonstrated that the PRS 
correctly identified 78.1% of children tested.  Additionally, to increase the 
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validity of the BASC, the PRS has built-in validity checks to ensure that 
the responder understands the instrument, responds honestly, and pays 
close attention to each item.  Median Cronbach alpha values were .81, 
.85, and .85 respectively for preschool, child, and adolescent levels.  
Test-retest reliability coefficients were .76, .84, and .82, respectively, 
while interrater reliability coefficients ranged from .46 to .71 (Hughes & 
Melson). 
 CBCL.  To measure the child’s emotional and behavioral 
functioning, the Child Behavior Checklist (Achenbach, 1991; Achenbach 
& Rescorla, 2000, 2001), which was developed in the 1960s, is 
completed by the child’s primary caregiver at the time of the child’s 
evaluation.  A multidimensional tool that assesses a range of behavioral 
and emotional problems, the CBCL includes multi-informant reports for 
parents, teachers, and other caregivers.  In the current study, the CBCL 
for ages 1½ to 5 years and the CBCL for ages 6 to 18 years were used.  
Respondents read a description of a behavioral or emotional problem 
and rate how true the behavior is for their child (currently and over the 
past two or six months, depending on the version) on a 3-point Likert-
type scale.  Choices range from “Not True” to “Very or Often True” with 
100 items on the CBCL for ages 1½ to 5 years and 113 items on the 
CBCL for ages 6 to 18 years.  This measure yields profile scores 
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identifying the presence of affective problems, somatic problems, anxiety 
problems, attention deficit/hyperactivity problems, oppositional defiant 
problems, and conduct problems (Achenbach, 1991; Achenbach & 
Rescorla, 2000, 2001).  The current study utilized the internalizing and 
externalizing scores as a measure of emotional functioning. 
 The CBCL appears to be a reliable instrument as individual item 
intraclass correlations (ICC) of greater than .90 were obtained between 
item scores obtained from mothers filling out the CBCL at 1-week 
intervals, mothers filling out the CBCL on their clinically-referred children, 
and three different interviewers obtaining CBCLs from parents of 
demographically matched triads of children.  Stability of ICCs over a 3-
month period was .84 for behavior problems and .97 for social 
competencies.  Test-retest reliability of mothers’ ratings was .89 
(Achenbach & Rescorla, 2000, 2001).  Furthermore, the CBCL appears 
to have good validity as tests of criterion-related validity using clinical 
status as the criterion (referred/non-referred) support the validity of the 
instrument.  Importantly, demographic variables such as race and SES 
accounted for a relatively small proportion of score variance (Achenbach 
& Rescorla, 2000, 2001). 
 ECBI.  The Eyberg Child Behavior Inventory (ECBI) is a widely 
used parent rating scale that was developed by Sheila Eyberg in 1999.  
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Designed for use as a quick screening tool in clinical pediatric settings to 
quantify disruptive behavior in children between 2 and 16 years of age, 
the measure contains 36 items rated on two scales.  To obtain a 
measure of conduct problem severity, parents/caregivers rate the 
frequency of behaviors on a Likert-type Intensity Scale from Never (1) to 
Sometimes (4) to Always (7).  To determine a measure of parental 
tolerance, parents/caregivers then complete the Problem Scale by 
circling “Yes” or “No,” to indicate whether they consider each behavior to 
be a problem (Eyberg & Pincus, 1999). 
 In psychometric studies, both scales have shown high internal 
consistency and stability, as well as convergent and discriminant validity 
with ratings scales of psychopathology and behavioral observation 
measures.  Internal consistency reliability studies indicated Cronbach 
alpha values for the ECBI Intensity Scale ranging from .95 to .98.  Kuder-
Richardson 20 values for the ECBI Problem Scale were reported to be in 
the .90s as well.  Test-retest reliability ranged between the 70s and 80s 
for both the Intensity and Problem scales.  Interrater reliability for parents 
ranges from .61 to .86 (Rich & Eyberg, 2001). 
 Medical/Physical Examination.  The infant/child’s head 
circumference was obtained by one of two methods.  A short medical 
evaluation was conducted by the developmental pediatrician on staff at 
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the facility, with the information recorded on the child’s medical chart.  
The second method utilized a Child Health Screening Physical Indicators 
of Development (PID) evaluation that was conducted by a clinic staff 
member.  In each case, the information included the child’s weight, 
height, and head circumference.  For the current study, only the child’s 
head circumference percentile was reported. 
Research Design 
 In this study, the independent variable was a status variable, in 
that the participants were grouped by prenatal exposure of 
methamphetamine and other illicit drugs on fetuses.  The constructs of 
cognitive functioning, language functioning, motor functioning, emotional 
functioning, behavioral functioning, and head circumference were the 
dependent variables, as measured by scores obtained on the: BSID-II, 
BSID-III , WPPSI-R, and WPPSI-III (cognitive functioning); BSID-II, 
BSID-III, PLS-3, and PLS-4 (language functioning); BSID-II, BSID-III, and 
PDMS-2 (motor functioning); BASC-PRS and CBCL (emotional 
functioning); ECBI (behavioral functioning); and PID or medical 
examination (head circumference). 
 An alpha level of .05 was used for all statistical tests, with r 
calculated as the effect size.  The data analyses for the study began with 
descriptive statistics to determine whether any of the demographic 
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variables were significantly related to any of the outcome variables (i.e., 
child cognitive, language, motor, emotional and behavioral functioning, 
and head circumference). 
 Simple, univariate between-groups analysis of variance (ANOVA) 
tests were used to determine if children who were prenatally exposed 
exclusively to methamphetamine differed significantly from those who 
were exposed to other substances including methamphetamine and 
those who were exposed to other substances not including 
methamphetamine. 
 Ancillary analysis utilizing T-tests were also conducted to compare 
the cognitive, motor, language, emotional and behavioral functioning 
scores, and head circumference of children in the current sample to 
published norms on each of the measures.  These were conducted to 
determine if the scores of children with prenatal exposure to 
methamphetamine differ significantly from the normative population or 
what is expected in children without prenatal exposure to illicit 
substances.  According to an unpublished manuscript by Gurwitch et al., 
infants with prenatal exposure to methamphetamine obtained cognitive 
mean scores (BSID-II MDI, WPPSI-R, and WPPSI-III), language mean 
scores (PLS-3), and motor mean scores (BSID-II PDI) that were 
Multidimensional Functioning 
 65
significantly lower than the published norms for each of the tests utilized 
(Gurwitch et al., 2008). 
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Chapter 4 
Results 
Statistical Analyses 
 Screening for accuracy of data entry and missing values 
distributions was conducted prior to the main data analysis.  
Methamphetamine exposure, cognitive development, language 
development, motor development, emotional development, behavioral 
scores, and head circumference were examined.  The primary 
problematic screening issue in the current dataset was missing data and 
children whose prenatal exposure was unknown.  Hence, the resulting 
sample size was 288 for cognitive scores, 540 for language scores, 216 
for motor scores, 169 for emotional scores, 367 for behavioral scores, 
and 1469 for head circumference measurements.  Individuals whose 
prenatal exposure was unknown are noted.  Descriptive statistics were 
used to determine the demographic results, ANOVA analyses were used 
to examine the research questions, and T-tests were used to compare 
the sample to the published norms of each assessment measure. 
Demographic Results 
 The Children.  The sample consisted of 1556 children with 
prenatal substance exposure.  Of the 1556, 108 (7%) were prenatally 
exposed to methamphetamine only, 487 (31%) were prenatally exposed 
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to methamphetamine plus other substances, 872 (56%) were exposed to 
substances not including methamphetamine, and 89 (6%) were exposed 
to unknown substances. 
 The sample consisted of 875 males (56%) and 677 females 
(44%); the gender of 4 children was unknown.  The mean age was 38.23 
months, with a minimum age of 2 months and a maximum age of 96 
months.  Children designated as Caucasian made up 52% of the sample.  
The remaining sample fell into a distribution of African American (19%), 
American Indian (12%), Multiracial (11%), and Hispanic (5%).  Only 5 
children in the sample were listed as Asian.  The mean height percentile 
was 34th, the mean weight percentile was 45th, and the mean head 
circumference percentile was 40th. 
 There were 108 children in the sample with methamphetamine 
only prenatal exposure.  Of this group, 74 (68%) were males and 34 
(32%) were females.  The mean age of children at the time of their clinic 
visit was 30 months.  Children designated as Caucasian made up 72% of 
the group, while 15% were Native Americans, 9% were Multiracial, 3% 
were Hispanic, and less than 1% were African American.  The mean 
height percentile was 29th, the mean weight percentile was 41st, and the 
mean head circumference percentile was 41st. 
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 Biological Mothers of the Children.  The biological mothers of 
children in the sample indicated (or the information was provided by the 
current caregiver or child’s medical records) that only 21% received 
prenatal care during their first trimester of pregnancy, while 77% did not.  
Regarding second trimester prenatal care, 31% received care and 68% 
did not receive care.  During the third trimester, 33% received prenatal 
care, while 65% received no care.  The mean education level of the 
biological mothers was 10th grade.  Regarding marital status, 56% of 
mothers were single, divorced, cohabitating, separated, or widowed, 
while 20% were married.  Caucasians were the largest group 
represented at 59%, followed by African Americans with 16%, American 
Indians at 10%, and Hispanics at 4%.  Only 5 of the biological mothers 
were listed as Asian.  In an alarming number of cases (73% of the 
sample), abuse or neglect had been reported at one time or another 
against the biological mother.  It is unknown whether the abuse/neglect 
was regarding the child in the sample or another child in the home.  
Additionally, an overwhelming number of biological mothers reported 
experiencing domestic violence (75%). 
 The biological mothers of children in the methamphetamine only 
group indicated (or the information was provided by the current caregiver 
or child’s medical records) that only 10% received prenatal care during 
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their first trimester of pregnancy, while 86% did not.  Regarding second 
trimester prenatal care, 24% received care and 72% did not receive care.  
During the third trimester, 32% received prenatal care, while 64% 
received no care.  The mean education level of the biological mothers 
was 10th grade.  Regarding marital status, 51% of mothers were single, 
divorced, cohabitating, separated, or widowed, while 21% were married.  
Caucasians were the largest group represented at 68%, followed by 
American Indians at 14%, and those listing Other as their race made up 
7% of this group.  Again, in an alarming number of cases (78% of the 
sample), abuse or neglect had been reported at one time or another 
against the biological mother.  It is unknown whether the abuse/neglect 
was regarding the child in the sample or another child in the home.  
Additionally, an overwhelming number of biological mothers reported 
experiencing domestic violence (82%). 
 Current Primary Caregivers of the Children.  For children in the 
sample, the mean length of time with the current primary caregiver was 
24 months.  Regarding relationship to the primary caregiver, 35% lived 
with a foster parent, 21% lived with an adoptive parent, 18% lived with a 
grandparent, 17% lived with their biological parent, and 7% lived with 
another relative.  Caucasians made up the largest group of current 
primary caregivers at 66%, followed by African Americans at 14%, 
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Multiracials at 6%, and Hispanics at 2%.  No Asians were represented in 
this group.  Regarding marital status, 61% were married, while 28% were 
single, divorced, cohabitating, separated, or widowed.  The mean 
education level of current primary caregivers was 11th grade.  A table of 
demographic information for the sample, along with demographic graphs 
can be found in Appendices A, B, C, and D. 
 For children in the group with methamphetamine only prenatal 
exposure, the mean length of time with their current primary caregiver 
was 15 months.  Of children in the sample, 49% lived with a foster 
parent, 20% lived with a grandparent, 16% lived with their biological 
parent, 10% lived with an adoptive parent, and 5% lived with another 
relative.  Caucasians again made up the largest group of current primary 
caregivers at 77%, followed by Native Americans at 8%, and less than 
1% were listed as African Americans.  Regarding marital status, 69% 
were married, while 21% were single, divorced, cohabitating, separated, 
or widowed.  The mean education level of current primary caregivers 
was 11th grade.   
Research Question ANOVA Results 
 Research question one.  Are there differences in the cognitive 
scores of children who have been prenatally exposed to 
methamphetamine only, children who have been prenatally exposed to 
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methamphetamine plus other substances, and children who have been 
prenatally exposed to other substances not including 
methamphetamine? 
 As shown in Table 1, results of ANOVA indicate no significant 
differences between exposure groups on scores of cognitive 
development F(3,288) = .087, p = 0.46.  That is, the differences between 
the cognitive scores of children who were prenatally exposed to 
methamphetamine only, children who were prenatally exposed to 
methamphetamine plus other substances, and children who were 
prenatally exposed to other substances not including methamphetamine 
did not reach statistical significance. 
Table 1 
Cognitive Summary 
Variable Df F 
value 
Pr(>F
) 
 
Exposure 3 0.87 0.46  
Age 1 12.37 0.00 *** 
Sex 1 0.05 0.83  
Race 4 2.43 0.05 * 
HeightLogit 1 0.99 0.32  
WeightLogit 1 1.93 0.17  
Bio Mom Education 1 4.15 0.04 * 
Bio Mom Marital 5 0.40 0.85  
Bio Dad Education 1 3.57 0.60 . 
Prenatal Care 1st Tri 1 0.12 0.73  
Prenatal Care 2nd Tri 1 5.41 0.21 * 
Prenatal Care 3rd Tri 1 2.53 0.11  
Abuse/Neglect 1 0.06 0.80  
Domestic Violence 1 0.06 0.81  
DHS Custody 1 1.40 0.24  
Primary Caregiver Changes 1 0.22 0.64  
Primary Caregiver Relation 5 2.66 0.02 * 
Length Time w/ Current CG 1 1.84 0.18  
Residuals 288    
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*p < .05.  **p < .01.  ***p < .001 
 
 Research question two.  Are there differences in the language 
scores of children who have been prenatally exposed to 
methamphetamine only, children who have been prenatally exposed to 
methamphetamine plus other substances, and children who have been 
prenatally exposed to other substances not including 
methamphetamine? 
 As shown in Tables 2 and 3, results of ANOVA indicate 
nonsignificant differences between exposure groups on scores of 
language development at the .05 level, F(3, 540) = 2.38, p = .069.  
However, exposure was not found to account for a large amount of 
variance as the exposure variable dropped only slightly below p=.07 and 
the R-squared was never above 10%.  Multiple R-squared: 0.07307; 
adjusted R-squared: 0.03702; F-statistic: 2.027 on 21; and 540 DF; p-
value: 0.004605.  In the results, methamphetamine only exposure had 
the lowest mean language summary while those with unknown exposure 
had the highest. 
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Table 2 
Language Summary 
Variable Df F value Pr(>F)  
Exposure 3 2.38 0.06905 . 
Age 1 2.71 0.10024  
Race 5 2.39 0.03670 * 
Height Logit 1 5.09 0.02443 * 
Weight Logit 1 2.19 0.13939  
Bio Mom Marital Status 5 0.51 0.77165  
Primary Caregiver 
Relationship 
5 2.19 0.05401 . 
Residuals 540    
*p < .05.  **p < .01.  ***p < .001 
 
Table 3 
 
Language Summary Coefficients 
Coefficients Estimate Std. Error 
T value Pr(>|t|)  
(Intercept) 88.40 3.97 22.25 < 2e-16 *** 
Exposure Meth only 0     
Exposure Meth plus 2.73 3.32 0.83 0.41  
Exposure Other 1.11 3.27 0.34 0.73  
Exposure Unknown 8.98 4.44 2.02 0.04 * 
Age -0.09 0.04 -2.33 0.02 * 
Race White 0     
Race African American -0.93 2.20 -0.42 0.67  
Race Native American 0.21 2.32 0.09 0.93  
Race Hispanic -7.42 3.12 -2.38 0.02 * 
Race Asian 39.40 17.44 2.26 0.02 * 
Race Multiracial -2.58 2.60 -0.99 0.32  
Height Logit 0.24 0.64 0.37 0.71  
Weight Logit 0.85 0.58 1.47 0.14  
Bio Mom Marital Single 0     
Bio Mom Marital Married -0.90 1.77 -0.51 0.61  
Bio Mom Marital Divorced 5.01 3.45 1.45 0.15  
Bio Mom Marital Widow -4.46 17.60 -0.25 0.80  
Bio Mom Marital Separated 0.86 4.99 0.17 0.86  
Mio Mom Marital Cohabitate -0.64 3.50 -0.18 0.85  
Primary Caregiver Relationship Bio Parent 0     
Primary Cgiver Relationship Foster 3.06 2.29 1.33 0.18  
Primary Cgiver Relationship Adoptive 7.57 2.40 3.15 0.00 ** 
Primary Cgiver Relationship Grandparent 3.63 2.30 1.58 0.11  
Primary Cgiver Relationship Other Relativ 5.16 3.13 1.64 0.10  
Primary Cgiver Relationship Other -0.96 7.36 -0.13 0.89  
*p < .05.  **p < .01.  ***p < .001 
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 Research question three.  Are there differences in the motor 
scores of children who have been prenatally exposed to 
methamphetamine only, children who have been prenatally exposed to 
methamphetamine plus other substances, and children who have been 
prenatally exposed to other substances not including 
methamphetamine? 
 As shown in Table 4, results of ANOVA indicate nonsignificant 
differences between exposure groups on scores of motor development at 
the .05 level, F(3, 216) = 2.29, p = .08. 
Table 4 
Motor Summary 
Variables Df F value Pr(>F)  
Exposure 3 2.29 0.08 . 
Age 1 0.34 0.56  
Sex 1 0.28 0.60  
Race 4 1.07 0.37  
HeightLogit 1 0.02 0.88  
WeightLogit 1 1.60 0.21  
Bio Mom Education 1 0.02 0.89  
Bio Mom Marital 4 0.69 0.60  
Bio Dad Education 1 1.34 0.25  
Prenatal Care 1st Tri 1 0.99 0.32  
Prenatal Care 2nd Tri 1 4.70 0.03 * 
Prenatal Care 3rd Tri 1 0.47 0.49  
Abuse/Neglect 1 0.05 0.82  
Domestic Violence 1 0.19 0.66  
DHS Custody 1 0.57 0.45  
Primary Caregiver Changes 1 0.90 0.34  
Primary Caregiver Relation 5 1.01 0.41  
Length Time w/ Current CG 1 0.46 0.50  
HeightLogit: WeightLogit 1 0.64 0.43  
Residuals 216    
*p < .05.  **p < .01.  ***p < .001 
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 Research question four.  Are there differences in the emotional 
functioning scores of children who have been prenatally exposed to 
methamphetamine only, children who have been prenatally exposed to 
methamphetamine plus other substances, and children who have been 
prenatally exposed to other substances not including 
methamphetamine? 
 As shown in Table 5, results of ANOVA indicate no significant 
differences between exposure groups on scores of emotional 
development, F(3, 169) = 2.45, p = .65.  That is, the differences between 
the emotional functioning scores of children who were prenatally 
exposed to methamphetamine only, children who were prenatally 
exposed to methamphetamine plus other substances, and children who 
were prenatally exposed to other substances not including 
methamphetamine did not reach statistical significance. 
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Table 5 
Emotional Summary 
Variables Df F value Pr(>F)  
Exposure 3 2.45 0.65 . 
Age 1 11.29 0.00 *** 
Sex 1 0.16 0.69  
Race 4 1.30 0.27  
HeightLogit 1 1.20 0.27  
WeightLogit 1 4.14 0.43 * 
Bio Mom Education 1 0.04 0.84  
Bio Mom Marital 5 1.73 0.13  
Bio Dad Education 1 1.14 0.29  
Prenatal Care 1st Tri 1 0.18 0.67  
Prenatal Care 2nd Tri 1 3.79 0.05 . 
Prenatal Care 3rd Tri 1 0.51 0.48  
Abuse/Neglect 1 0.09 0.76  
Domestic Violence 1 0.74 0.39  
DHS Custody 1 1.74 0.19  
Primary Caregiver Changes 1 0.02 0.90  
Primary Caregiver Relation 5 1.24 0.29  
Length Time w/ Current CG 1 0.01 0.93  
HeightLogit: WeightLogit 1 0.52 0.47  
Residuals 169    
*p < .05.  **p < .01.  ***p < .001 
 
 Research question five.  Are there differences in the behavioral 
functioning scores of children who have been prenatally exposed to 
methamphetamine only, children who have been prenatally exposed to 
methamphetamine plus other substances, and children who have been 
prenatally exposed to other substances not including 
methamphetamine? 
 As shown in Table 6, results of ANOVA indicate no significant 
differences between exposure groups on scores of behavioral 
development, F(3, 367) = .83, p = .83.  That is, the differences between 
the behavioral functioning scores of children who were prenatally 
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exposed to methamphetamine only, children who were prenatally 
exposed to methamphetamine plus other substances, and children who 
were prenatally exposed to other substances not including 
methamphetamine did not reach statistical significance. 
Table 6 
 
Behavioral Summary 
Variables Df F value Pr(>F)  
Exposure 3 0.29 0.83  
Age 1 0.38 0.54  
Sex 1 0.58 0.45  
Race 5 0.74 0.59  
Height Logit 1 0.34 0.56  
Weight Logit 1 0.55 0.46  
Bio Mom Education 1 1.35 0.25  
Bio Mom Marital Status 5 0.56 0.73  
Bio Dad Education 1 0.15 0.70  
Prenatal Care 1st Trimester 1 1.66 0.20  
Prenatal Care 2nd Trimester 1 1.66 0.20  
Prenatal Care 3rd Trimester 1 2.64 0.11  
Abuse/Neglect 1 1.18 0.28  
Domestic Violence 1 1.18 0.28  
DHS Custody 1 1.34 0.25  
Primary Caregiver Changes 1 0.09 0.77  
Primary Caregiver Relationship 5 1.29 0.27  
Length of Time with Current 
Caregiver 
1 0.06 0.81  
Height Logit: Weight Logit 1 0.10 0.76  
Residuals 367    
*p < .05.  **p < .01.  ***p < .001 
 
 Research question six.  Are there differences in the head 
circumference measurements of children who have been prenatally 
exposed to methamphetamine only, children who have been prenatally 
exposed to methamphetamine plus other substances, and children who 
have been prenatally exposed to other substances not including 
methamphetamine? 
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 As shown in Tables 7, 8 and 9, analysis on head circumference 
was conducted controlling for height and weight (height logit and weight 
logit is an interaction between two continuous variables).  This suggests 
a significant effect for exposure on head circumference.  While 
methamphetamine plus other substances is 1 percentile point above 
methamphetamine only, other exposure and unknown exposure are near 
3.5 percentile points below methamphetamine only.  The residual 
standard error is 1.506 on 1469 degrees of freedom.  Multiple R-squared 
is 0.3559 while Adjusted R-squared is 0.3532.  This indicates a 
predicting of approximately 35% of the variance.  The F-statistic is 135.3 
with a p-value of < 2.2e-16 or p <.001.  It is interesting that Exposure 
becomes a better variable when height and weight are included in the 
model.  It might be expected that physical variables would account for 
much of the variance; however, Exposure's p-value drops from .13 to .03 
Table 7 
Head Circumference Summary 
Variables Df F value Pr(>F)  
Exposure 3 2.95 0.03 * 
Height Logit 1 550.18 <2.2e-16 *** 
Weight Logit 1 196.18 <2.2e-16 *** 
Height Logit: Weight Logit 1 56.43 1.006e-13 *** 
Residuals 1469    
*p < .05.  **p < .01.  ***p < .001 (i.e. 2.2e-16 indicates 2.2 * 10^-16, which is also 
.00000000000000022.  This is typically reported as < .001). 
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Table 8 
Head Circumference 
 Df F value Pr(>F)  
Exposure 3 1.91 0.13  
Residuals 1472    
*p < .05.  **p < .01.  ***p < .001 
 
Table 9 
 
Head Circumference Coefficients 
Coefficients Estimate Std. Error T value Pr(>|t|)  
(Intercept) -0.07 0.15 -0.45 0.65  
Exposure Meth only 0     
Exposure Meth plus 0.01 0.17 0.08 0.94  
Exposure Other -0.20 0.16 -1.28 0.20  
Exposure Unknown -0.25 0.22 -1.11 0.27  
Height Logit 0.17 0.03 5.39 8.36e-08  
Weight Logit 0.31 0.03 9.29 <2e-16  
Height Logit: Weight Logit -0.07 0.01 -7.51 1.01e-13  
*p < .05.  **p < .01.  ***p < .001 
 
Comparison of Sample to Published Norms 
 WPPSI FSIQ Cognitive T-Test.  Using T-tests, results found that 
the methamphetamine-only group was statistically significantly different 
from the normative mean, t = -4.893, p < .001.  As shown in Tables 10 
and 11, the methamphetamine-only group had a mean FSIQ of 87.89, 
which puts them in approximately the 20th percentile with a range of 51 – 
109.  The standard deviation (14.337) indicated a large range of 
variability. 
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Table 10 
WPPSI FSIQ Cognitive T-Test Results 
One-Sample Statistics 
WPPSI N Mean SD Std. Error Mean 
FSIQ 33 87.79 14.337 2.496 
 
Table 11 
WPPSI FSIQ Cognitive T-Test Results 2 
One-Sample Test 
 Test Value = 100                                      
 
t df 
Sig. 
(2-tailed) Mean Difference 
95% Confidence Interval of the 
Difference 
WPPSI Lower Upper 
FSIQ -4.893 32 .000 -12.212 -17.30 -7.13 
 
 PLS Language Total T-Test.  As shown in Tables 12 and 13, the 
methamphetamine-only group is statistically significantly different from 
the normative mean, t = -2.531, p = .016.  Statistically significant results 
were likely influenced by high variability in scores, range of ages of 
subjects, and the small sample size.  The mean of 91.72 puts the group 
in the 27th – 30th percentiles.  Guidelines for the PLS-4 indicate scores of 
1.5 standard deviations (less than 85) are qualification for language 
improvement programs (Zimmerman et al., 2008). 
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Table 12 
PLS Language Total T-Test Results 
One-Sample Statistics 
PLS N Mean SD Std. Error Mean 
PLSTotalSS 36 91.72 19.626 3.271 
 
Table 13 
PLS Language Total T-Test Results 2 
One-Sample Test 
 Test Value = 100                                      
 
t df 
Sig. 
(2-tailed) 
Mean 
Difference 
95% Confidence Interval of 
the Difference 
PLS Lower Upper 
PLSTotalSS -2.531 35 .016 -8.278 -14.92 -1.64 
 
 PDMS Motor Functioning T-Test Results.  As indicated in Tables 
14 and 15 regarding overall motor functioning, the methamphetamine-
only sample was found to be statistically significantly different from the 
normative group on measures of total motor skills, t=-2.960, p=.006.  The 
sample was found to have lower scores on measures of total motor skills 
than the normative group.  Overall, the sample differs at the total level 
and the fine and gross level so the differences are more global rather 
than related to a particular type of motor control.  This may suggest that 
methamphetamine-only adversely affects motor control, in general. 
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Table 14 
PDMS Overall Motor T-Test Results 
One-Sample Statistics 
 N Mean Std. Deviation Std. Error Mean 
PeabodyTotalMotor 29 91.55 15.371 2.854 
 
Table 15 
PDMS Overall Motor T-Test Results 2 
One-Sample Test 
 Test Value = 100                                      
 
t df 
Sig. 
(2-tailed) 
Mean 
Difference 
95% Confidence Interval 
of the Difference 
 Lower Upper 
PeabodyTotalMotor -2.960 28 .006 -8.448 -14.29 -2.60 
 
 As indicated in Tables 16 and 17, in gross motor functioning, the 
methamphetamine-only sample (males and females combined) were 
found to be statistically significantly different from the normative group on 
measures of gross motor skills, t=-3.277, p=.003.  The sample was found 
to have lower scores on measures of gross motor skills than the 
normative sample. 
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Table 16 
PDMS Gross Motor T-Test Results 
One-Sample Statistics 
 N Mean Std. Deviation Std. Error Mean 
PeabodyGrossMotorQuotient 29 92.31 12.638 2.347 
 
Table 17 
PDMS Gross Motor T-Test Results 2 
One-Sample Test 
 Test Value = 100                                     
 
t df 
Sig. 
(2-tailed) 
Mean 
Difference 
95% Confidence 
Interval of the 
Difference 
 Lower Upper 
PeabodyGrossMotorQuotient -3.277 28 .003 -7.690 -12.50 -2.88 
 
 As indicated in Tables 18 and 19 regarding fine motor functioning, 
the methamphetamine-only sample was found to be statistically 
significantly different from the normative group on measures of fine 
motor skills, t=-3.048, p=.005.  The sample was found to have lower 
scores on measures of fine motor skills than the normative group. 
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Table 18 
PDMS Fine Motor T-Test Results 
One-Sample Statistics 
 N Mean Std. Deviation Std. Error Mean 
PeabodyFineMotorQuotient 29 89.55 18.460 3.428 
 
Table 19 
PDMS Fine Motor T-Test Results 2 
One-Sample Test 
 Test Value = 100                                      
 
t df 
Sig. 
(2-tailed) 
Mean 
Difference 
95% Confidence Interval 
of the Difference 
 Lower Upper 
PeabodyFineMotorQuotient -3.048 28 .005 -10.448 -17.47 -3.43 
 
 As indicated in Tables 20 and 21 regarding total motor functioning 
in males, the methamphetamine-only male sample was found to 
statistically significantly differ from the normative male group, t=-2.356, 
p=.028.  The sample was observed to have lower total motor skill scores 
than the normative male group. 
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Table 20 
PDMS Overall Motor – Males T-Test Results 
One-Sample Statistics 
 N Mean Std. Deviation Std. Error Mean 
PeabodyTotalMotor 22 90.59 16.741 3.569 
 
Table 21 
PDMS Overall Motor – Males T-Test Results 2 
One-Sample Test 
 Test Value = 99                                       
 
t df 
Sig. 
(2-tailed) 
Mean 
Difference 
95% Confidence Interval of 
the Difference 
 Lower Upper 
PeabodyTotalMotor -2.356 21 .028 -8.409 -15.83 -.99 
 
 As indicated in Tables 22 and 23 regarding gross motor 
functioning in males, the methamphetamine-only male sample was found 
to statistically significantly differ from the normative male sample on 
measures of gross motor skills, t=-2.523, p=.020.  The sample was 
observed to have lower gross motor scores than the normative samples.  
This means the differences observed at the overall level remain 
consistent in the gross motor level. 
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Table 22 
PDMS Gross Motor – Males T-Test Results 
One-Sample Statistics 
 N Mean Std. Deviation Std. Error Mean 
PeabodyGrossMotorQuotient 22 91.73 13.520 2.882 
 
Table 23 
PDMS Gross Motor – Males T-Test Results 2 
One-Sample Test 
 Test Value = 99                                      
 
t df 
Sig. 
(2-tailed) 
Mean 
Difference 
95% Confidence 
Interval of the 
Difference 
 Lower Upper 
PeabodyGrossMotorQuotient -2.523 21 .020 -7.273 -13.27 -1.28 
 
 As shown in Tables 24 and 25 regarding fine motor functioning in 
males, the methamphetamine-only male sample was found to be 
statistically significantly different from the normative male group on 
measures of fine motor skills, t=-2.608, p=.016.  The sample was 
observed to have lower fine motor scores than the normative male 
group.  Again, motor skills overall and at more specific levels of fine and 
gross were lower, presumably negatively impacted by methamphetamine 
exposure. 
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Table 24 
PDMS Fine Motor – Males T-Test Results 
One-Sample Statistics 
 N Mean Std. Deviation Std. Error Mean 
PeabodyFineMotorQuotient 22 87.82 20.111 4.288 
 
Table 25 
PDMS Fine Motor – Males T-Test Results 2 
One-Sample Test 
 Test Value = 99                                       
 
t df 
Sig. 
 (2-tailed) 
Mean 
Difference 
95% Confidence Interval 
of the Difference 
 Lower Upper 
PeabodyFineMotorQuotient -2.608 21 .016 -11.182 -20.10 -2.27 
 
 As indicated in Tables 26 and 27 regarding overall motor 
functioning in females, the methamphetamine-only female group was not 
found to statistically significantly differ from the normative female group 
on measures of total motor skills, t=-1.640, p=.152.  Data indicates that 
although the sample had lower scores, they did not meet significance.  
However, small sample size is an issue as there were only seven scores. 
Overall it does not appear that females in the sample showed significant 
differences as compared to the normative group.  Although this could be 
a result of too small a sample, the data trends could also point to an 
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increased susceptibility of males (over females) to the effects of 
methamphetamine on motor skills. 
Table 26 
PDMS Overall Motor – Females T-Test Results 
One-Sample Statistics 
 N Mean Std. Deviation Std. Error Mean 
PeabodyTotalMotor 7 94.57 10.374 3.921 
 
Table 27 
PDMS Overall Motor – Females T-Test Results 2 
One-Sample Test 
 Test Value = 101                                      
 
t df 
Sig. 
(2-tailed) 
Mean 
Difference 
95% Confidence Interval of 
the Difference 
 Lower Upper 
PeabodyTotalMotor -1.640 6 .152 -6.429 -16.02 3.17 
 
 As shown in Tables 28 and 29 regarding gross motor functioning 
in females, the methamphetamine-only female sample did not 
statistically significantly differ from the female normative sample on 
measures of gross motor skills, t=-1.546, p=.173.  The sample had lower, 
but not significantly lower, scores on gross motor.  Again, the small 
sample size is an issue, but it could be indicative of the same things 
mentioned regarding overall motor functioning. 
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Table 28 
PDMS Gross Motor – Females T-Test Result 
One-Sample Statistics 
 N Mean Std. Deviation Std. Error Mean 
PeabodyGrossMotorQuotient 7 94.14 10.024 3.789 
 
Table 29 
PDMS Gross Motor – Females T-Test Result 2 
One-Sample Test 
 Test Value = 100                                     
 
t df 
Sig.  
2-tailed) 
Mean 
Difference 
95% Confidence Interval of 
the Difference 
 Lower Upper 
PeabodyGrossMotorQuotient -1.546 6 .173 -5.857 -15.13 3.41 
 
 As shown in Tables 30 and 31 regarding gross motor functioning 
in females, the methamphetamine-only female sample did not 
statistically significantly differ from the female normative sample on 
measures of gross motor skills, t=-1.631, p=.154.  The sample had lower, 
but not significantly lower, scores on fine motor.  Although the sample is 
very small, it could indicate a true difference between the effects of 
methamphetamine on males and females. 
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Table 30 
PDMS Fine Motor – Females T-Test Result 
One-Sample Statistics 
 N Mean Std. Deviation Std. Error Mean 
PeabodyFineMotorQuotient 7 95.00 11.358 4.293 
 
Table 31 
PDMS Fine Motor – Females T-Test Result 2 
One-Sample Test 
 Test Value = 102                                      
 
t df 
Sig. 
(2-tailed) 
Mean 
Difference 
95% Confidence Interval 
of the Difference 
 Lower Upper 
PeabodyFineMotorQuotient -1.631 6 .154 -7.000 -17.50 3.50 
 
 BASC Emotional Functioning.  Due to the small sample sizes and 
high degree of variability among scores, data from the BASC could not 
be interpreted. 
 CBCL Emotional Functioning Internalizing and Externalizing 
Scales T-Test.  As indicated on Tables 32 and 33, the 
methamphetamine-only sample was found to statistically significantly 
differ from the clinical cutoff on the Internalizing Scale, t=-2.048, p=.047.  
The methamphetamine-only group was observed to have Internalizing 
Problems scores below the clinical and borderline clinical ranges.  The 
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methamphetamine-only sample was found to statistically significantly 
differ from the clinical cut-off on the Externalizing Scale, t=-4.199, 
p<.001.  The methamphetamine-only group was observed to have 
Externalizing Problems scores below the clinical and borderline clinical 
ranges. 
Table 32 
CBCL Emotional Internalizing & Externalizing Scales T-Test 
One-Sample Statistics 
 N Mean Std. Deviation Std. Error Mean 
CBCLIntTScore 40 58.30 17.598 2.783 
CBCLExternal TScore 40 55.18 13.293 2.102 
 
Table 33 
CBCL Emotional Internalizing & Externalizing Scales T-Test 2 
One-Sample Test 
 
Test Value = 64                                       
t df 
Sig. 
(2-tailed) 
Mean 
Difference 
95% Confidence Interval of the 
Difference 
Lower Upper 
CBCLIntTScore -2.048 39 .047 -5.700 -11.33 -.07 
CBCLExternal 
TScore 
-4.199 39 .000 -8.825 -13.08 -4.57 
 
 CBCL Emotional Functioning Internalizing and Externalizing 
Scales T-Test Male.  As shown in Tables 34 and 35, the 
methamphetamine-only males sample was found to statistically 
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significantly differ from the clinical cutoff on the Internalizing Scale, t=-
2.639, p=.014.  The methamphetamine-only group was observed to have 
Internalizing Problems scores below the clinical and borderline clinical 
ranges.  The methamphetamine-only sample was found to statistically 
significantly differ from the clinical cut-off on the Externalizing Scale, t=-
3.136, p=.004.  The methamphetamine-only group was observed to have 
Externalizing Problems below the clinical and borderline clinical ranges. 
Table 34 
CBCL Emotional Internalizing & Externalizing Scales Male 
One-Sample Statistics 
 N Mean Std. Deviation Std. Error Mean 
CBCLIntTScore 26 57.08 13.377 2.624 
CBCLExternal TScore 26 56.12 12.820 2.514 
 
Table 35 
CBCL Emotional Internalizing & Externalizing Scales Male 2 
One-Sample Test 
 
Test Value = 64                                       
t df 
Sig. 
(2-tailed) 
Mean 
Difference 
95% Confidence Interval 
of the Difference 
Lower Upper 
CBCLIntTScore -2.639 25 .014 -6.923 -12.33 -1.52 
CBCLExternal 
TScore 
-3.136 25 .004 -7.885 -13.06 -2.71 
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 CBCL Emotional Functioning Internalizing and Externalizing 
Scales T-Test Female.  As shown in Tables 36 and 37, no statistically 
significant difference was observed between the methamphetamine-only 
female group and the borderline clinical cutoff on the Internalizing 
Problems scale, t=.089, p=.930.  The mean Internalizing Problem score 
indicates the sample falls within the borderline clinical range, but does 
not meet the criteria for the clinical range.  No statistically significant 
difference was observed between the methamphetamine-only female 
group and the Externalizing Problem scale borderline clinical cutoff, t=-
1.701, p=.113.  The mean Externalizing Problems scores for the group 
did not meet the threshold for borderline clinical range, which the CBCL 
sets at T-scores of 60 through 63, or approximately the 84th through the 
90th percentiles, and the clinical range at T > or = 64. 
 
Table 36 
CBCL Emotional Internalizing & Externalizing Scales Female 
One-Sample Statistics 
 N Mean Std. Deviation Std. Error Mean 
CBCLIntTScore 14 60.57 24.009 6.417 
CBCLExternal TScore 14 53.43 14.458 3.864 
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Table 37 
CBCL Emotional Internalizing & Externalizing Scales Female 2 
One-Sample Test 
 
Test Value = 60                                       
t df 
Sig. 
(2-tailed) 
Mean 
Difference 
95% Confidence Interval of 
the Difference 
Lower Upper 
CBCLIntTScore .089 13 .930 .571 -13.29 14.43 
CBCLExternal 
TScore 
-1.701 13 .113 -6.571 -14.92 1.78 
 
 ECBI Behavioral Functioning Problem Scale T-Test.  As shown in 
Tables 38 and 39, the methamphetamine-only sample (males and 
females combined, 24-82 months) was not found to be statistically 
significantly different from the restandardized normative sample (all 
children ages 2-6 years) on the Problem Scale, t = -1.330, p = .188. 
Table 38 
ECBI Behavioral Functioning Problem Scale T-Test 
One-Sample Statistics 
ECBI Problem N Mean SD Std. Error Mean 
EybergProblem 65 4.97 8.068 1.001 
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Table 39 
ECBI Behavioral Functioning Problem Scale T-Test 2 
One-Sample Test 
 Test Value = 6.3                                     
 
t df 
Sig. 
(2-tailed) 
Mean 
Difference 
95% Confidence Interval 
of the Difference 
 Lower Upper 
Eyberg 
Problem 
-1.330 64 .188 -1.331 -3.33 .67 
 
 ECBI Behavioral Functioning Intensity Scale T-Test.  As shown in 
Tables 40 and 41, the methamphetamine-only sample (males and 
females combined, 24-82 months) was statistically significantly different 
from the restandardized normative sample (all children ages 2-6 on the 
Intensity Scale, t = -4.277, p < .001.  The methamphetamine-only sample 
had lower scores on the Intensity Scale, but the standard deviation is 
approximately twice that of the normative sample, indicating a large 
amount of variability in the sample. 
Table 40 
ECBI Behavioral Functioning Intensity Scale T-Test 
One-Sample Statistics 
 N Mean SD Std. Error Mean 
EybergIntensity 65 61.54 70.990 8.805 
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Table 41 
ECBI Behavioral Functioning Intensity Scale T-Test 2 
One-Sample Test 
 Test Value = 99.2                                     
 
t df Sig.(2-tailed) Mean Difference 
95% Confidence Interval 
of the Difference 
 Lower Upper 
Eyberg 
Intensity 
-
4.277 
64 .000 -37.662 -55.25 -20.07 
  
 ECBI Behavioral Functioning Problem and Intensity Scales by 
Sex.  As shown in Tables 42, 43, and 44, no statistically significant 
differences were observed on either scale between methamphetamine-
only males and methamphetamine-only females.  Intensity F(1, 63) = 
.209, p = .649, Problem F(1, 63) = .103, p = .749. 
Table 42 
ECBI Behavioral Functioning Problem/Intensity Scales – Sex 
Descriptives 
 
N Mean SD Std. Error 
95% Confidence 
Interval for Mean 
Min Max Lower  Upper  
Eyberg 
Problem 
Male 46 4.76 8.409 1.240 2.26 7.26 0 28 
Female 19 5.47 7.366 1.690 1.92 9.02 0 22 
Total 65 4.97 8.068 1.001 2.97 6.97 0 28 
Eyberg 
Intensity 
Male 46 58.93 72.074 10.627 37.53 80.34 0 216 
Female 19 67.84 69.804 16.014 34.20 101.49 0 179 
Total 65 61.54 70.990 8.805 43.95 79.13 0 216 
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Table 43 
ECBI Behavioral Functioning Problem/Intensity Scales – Sex 2 
Test of Homogeneity of Variances 
 Levene Statistic df1 df2 Sig. 
EybergProblem .038 1 63 .846 
EybergIntensity .022 1 63 .883 
 
Table 44 
ECBI Behavioral Functioning Problem/Intensity Scales – Sex 3 
ANOVA Df F Sig. 
EybergProblem Between Groups 1 .103 .749 
Within Groups 63   
Total 64   
EybergIntensity Between Groups 1 .209 .649 
Within Groups 63   
Total 64   
 
 ECBI Behavioral Functioning Problem ScaleT-Test Males.  As 
shown in Tables 45 and 46, no statistically significant difference was 
observed between the methamphetamine-only males (ages 24-82 
months) and the restandardized normative group (males ages 2-6 years) 
on the Problem Scale, t = -.999, p = .323. 
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Table 45 
ECBI Behavioral Functioning Problem Scale T-Test Male 
One-Sample Statistics 
 N Mean Std. Deviation Std. Error Mean 
EybergIntesity 46 4.76 8.409 1.240 
 
Table 46 
ECBI Behavioral Functioning Problem Scale T-Test Male 2 
One-Sample Test 
 
Test Value = 6.0                                      
t df Sig. (2-tailed) 
Mean 
Difference 
95% Confidence Interval of 
the Difference 
Lower Upper 
EybergIntesity -.999 45 .323 -1.239 -3.74 1.26 
 
 ECBI Behavioral Functioning Problem ScaleT-Test Females.  As 
shown in Tables 47 and 48, no statistically significant difference was 
observed between the methamphetamine-only females (ages 24-82 
months) and the restandardized normative group (females ages 2-6 
years) on the Problem Scale, t = 1.629, p = .138.  Again, it appears that 
females in the sample had higher scores than the normative group, but 
the small sample size makes interpretation difficult as to whether the 
difference occurred simply in this small sample of females or is indicative 
of a methamphetamine-group difference. 
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Table 47 
ECBI Behavioral Functioning Problem Scale T-Test Female 
One-Sample Statistics 
 N Mean Std. Deviation Std. Error Mean 
EybergProblem 10 10.40 7.183 2.272 
 
Table 48 
ECBI Behavioral Functioning Problem Scale T-Test Female 2 
One-Sample Test 
 
Test Value = 6.7                                      
t df Sig. (2-tailed) 
Mean 
Difference 
95% Confidence Interval of 
the Difference 
Lower Upper 
EybergProblem 1.629 9 .138 3.700 -1.44 8.84 
 
 ECBI Behavioral Functioning Intensity ScaleT-Test Males.  As 
shown in Tables 49 and 50, methamphetamine-only males (ages 24-82 
months) were observed to statistically significantly differ from the 
restandardized normative group (males ages 2-6 years) on the Intensity 
Scale, t = -3.648, p = .001.  The methamphetamine-only males had lower 
scores on the Intensity Scale; however, the standard deviation was 
double that in the normative group. 
 
Table 49 
ECBI Behavioral Functioning Intensity Scale T-Test Male 
One-Sample Statistics 
 N Mean Std. Deviation Std. Error Mean 
EybergIntensity 46 58.93 72.074 10.627 
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Table 50 
ECBI Behavioral Functioning Intensity Scale T-Test Male 2 
One-Sample Test 
 
Test Value = 97.7                                     
t df Sig. (2-tailed) 
Mean 
Differenc
e 
95% Confidence Interval of 
the Difference 
Lower Upper 
EybergIntensity -3.648 45 .001 -38.765 -60.17 -17.36 
 
 ECBI Behavioral Functioning Intensity ScaleT-Test Females.  As 
shown in Tables 51 and 52, methamphetamine-only females (ages 24-82 
months) were observed to statistically significantly differ from the 
restandardized normative group (females ages 2-6 years) on the 
Intensity Scale, t = 2.770, p = .022.  Although the methamphetamine-only 
females had higher scores on the Intensity Scale with the standard 
deviation approximately equivalent to that in the normative group, the 
sample included only ten individuals.  For this reason, it is difficult to 
know whether it is due to being a part of the methamphetamine group or 
is just a function of this particular sample. 
 
Table 51 
ECBI Behavioral Functioning Intensity Scale T-Test Female 
One-Sample Statistics 
 N Mean Std. Deviation Std. Error Mean 
EybergIntensity 10 128.90 31.628 10.002 
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Table 52 
ECBI Behavioral Functioning Intensity Scale T-Test Female 2 
One-Sample Test 
 
Test Value = 101.2                                    
t df 
Sig. 
(2-tailed) 
Mean 
Difference 
95% Confidence Interval of the 
Difference 
Lower Upper 
EybergIntensity 2.770 9 .022 27.700 5.07 50.33 
 
 Height, Weight, and Head Circumference.  As shown in Table 53, 
the methamphetamine-only sample (ages 3-76 months) means for height 
percentile fell into the 30th percentile, weight fell into the 42nd percentile, 
and head circumference fell into the 43rd percentile. 
Table 53 
Height, Weight, and Head Circumference 
Descriptive Statistics 
 N Range Minimum Maximum Mean Std. Deviation 
HeightPercentile 99 87 3 90 30.07 23.834 
WeightPercentile 99 95 4 99 42.20 27.314 
HeadPercentile 97 96 2 98 43.30 25.282 
Valid N (listwise) 96      
 
 As shown in Tables 54 and 55 regarding the height of males and 
females, the methamphetamine-only sample was found to be statistically 
significantly different from the normative mean of 50th percentile, t=-
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8.320, p<.001.  The children in the sample were shorter than the mean 
scores of children in the normative group. 
Table 54 
Height – Males and Females T-Test Results 
One-Sample Statistics 
 N Mean Std. Deviation Std. Error Mean 
HeightPercentile 99 30.07 23.834 2.395 
 
Table 55 
Height – Males and Females T-Test Results 2 
One-Sample Test 
 Test Value = 50                                       
 
t df 
Sig. 
(2-tailed) 
Mean 
Difference 
95% Confidence Interval of the 
Difference 
 Lower Upper 
HeightPercentile -8.320 98 .000 -19.929 -24.68 -15.18 
 
 As shown in Tables 56 and 57 regarding the weight of males and 
females, the methamphetamine-only sample was found to be statistically 
significantly different from the normative mean of 50th percentile on 
weight, t=-2.841, p=.005.  This indicates that children in the sample had 
lower weights than the mean weight of children in the normative group. 
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Table 56 
Weight – Males and Females T-Test Results 
One-Sample Statistics 
 N Mean Std. Deviation Std. Error Mean 
WeightPercentile 99 42.20 27.314 2.745 
 
Table 57 
Weight – Males and Females T-Test Results 2 
One-Sample Test 
 Test Value = 50                                       
 
t df 
Sig. 
(2-tailed) 
Mean 
Difference 
95% Confidence Interval of 
the Difference 
 Lower Upper 
WeightPercentile -2.841 98 .005 -7.798 -13.25 -2.35 
 
 As shown in Tables 58, 59, and 60 regarding height, weight, and 
head circumference in methamphetamine-only males versus females, 
the ANOVA was not significant for either weight or head circumference, 
F(1,97)=.611, p=.436 and F(1,97)=.089, p=.767.  Therefore, there were 
no statistically significant difference between male and females on 
weight or head circumference.  A Levine Test of Homogeneity of 
Variance was significant for height percentile indicating the assumptions 
of equivalent variance between groups necessary for ANOVA were not 
met.  This may be due to unequal sample sizes (68 versus 31); however, 
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it calls into question the validity of the comparison of the two means 
(32nd percentile for males and 24th for females).  This test shows no 
statistically significant difference F(1,97)=2.670, p=.106; however, as 
basic assumptions of ANOVA were not met, the interpretation may not 
be accurate. 
Table 58 
Height, Weight, and Head Circumference – Males and Females 
Descriptives 
  
N Mean SD 
Std. 
Error 
95% Confidence 
Interval for Mean 
Minimum Maximum 
  Lower 
Bound 
Upper 
Bound 
Height 
Percentile 
Male 68 32.69 26.159 3.172 26.36 39.02 3 90 
Female 31 24.32 16.664 2.993 18.21 30.44 3 65 
Total 99 30.07 23.834 2.395 25.32 34.82 3 90 
Weight 
Percentile 
Male 68 40.75 27.779 3.369 34.03 47.47 5 95 
Female 31 45.39 26.429 4.747 35.69 55.08 4 99 
Total 99 42.20 27.314 2.745 36.75 47.65 4 99 
Head 
Percentile 
Male 66 42.77 23.529 2.896 36.99 48.56 2 95 
Female 31 44.42 29.051 5.218 33.76 55.08 2 98 
Total 97 43.30 25.282 2.567 38.20 48.39 2 98 
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Table 59 
Height, Weight, and Head Circumference – Levene Statistic 
Test of Homogeneity of Variances 
 Levene Statistic df1 df2 Sig. 
HeightPercentile 12.540 1 97 .001 
WeightPercentile .672 1 97 .414 
HeadPercentile 2.023 1 95 .158 
 
Table 60 
Height, Weight, and Head Circumference – ANOVA Results 
ANOVA 
  
Sum of Squares df 
Mean 
Square F Sig. 
HeightPercentile Between Groups 1491.216 1 1491.216 2.670 .106 
Within Groups 54179.289 97 558.549   
Total 55670.505 98    
WeightPercentile Between Groups 457.855 1 457.855 .611 .436 
Within Groups 72658.105 97 749.053   
Total 73115.960 98    
HeadPercentile Between Groups 57.191 1 57.191 .089 .767 
Within Groups 61303.139 95 645.296   
Total 61360.330 96    
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Chapter 5 
Discussion 
Implications 
 Methamphetamine abuse is an emerging problem in all regions of 
the United States (Arria et al., 2006).  Despite the growing 
methamphetamine abuse problem, knowledge about the effects of 
prenatal methamphetamine exposure on the fetus is limited.  Prior to the 
current study, no study focused solely on the differences in the cognitive, 
language, motor, emotional functioning, behavioral functioning, and head 
circumference of young children prenatally exposed to 
methamphetamine only, young children prenatally exposed to 
methamphetamine plus other substances, and young children prenatally 
exposed to other substances not including methamphetamine.  The 
present study attempted to address these issues by utilizing a large 
database of scores on children who were referred to a specialty clinic 
specifically because of their prenatal exposure to substances. 
 Conclusions regarding the effects of prenatal methamphetamine 
exposure on cognitive, language, motor, emotional and behavioral 
development and head circumference cannot be drawn without 
considering other environmental and genetic variables.  Accordingly, 
demographic and environmental variables were also examined.  
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Analyses revealed that of the 1467 children whose prenatal substance 
exposure was identified, 41% had been exposed to methamphetamine 
with 59% of biological mothers confirming that they had abused 
methamphetamine while pregnant.  This is in agreement with studies 
finding that methamphetamine is a growing problem among pregnant 
women (CDC; 2005; Rawson et al., 2002).  Also consistent with the 
literature, over half (52%) of the exposed children in the larger sample 
were Caucasian, along with 72% of the children in the 
methamphetamine-only group.  Fifty-nine percent of biological mothers in 
the overall sample were listed as Caucasian, with 68% of the 
methamphetamine-only abusing group.  Interestingly, while the second 
largest group (19%) in the overall sample of children was made up of 
African Americans (with 16% of biological mothers), African American 
children and biological mothers accounted for less than 1% of the 
methamphetamine-only group.  American Indian children ranked third at 
12% of the overall sample (with 10% of biological mothers), but second 
(15%) in the methamphetamine-only group (with 14% of biological 
mothers).  This seems to also agree with previous findings suggesting 
that the methamphetamine problem is most prevalent in Caucasians, 
while substances such as cocaine and its derivatives are a more 
common problem in the African American population.  Additionally, that 
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methamphetamine is a growing concern with American Indians.  
Although the Asian population was very small in the methamphetamine 
exposed group, this mirrors the findings of the overall sample.  
Therefore, the numbers suggest that educational focus on the 
deleterious effects of methamphetamine might be best focused through 
programs targeting Caucasians and American Indians. 
 Disturbing findings in this study related to biological mothers.  An 
extremely large number, 86%, received no first trimester prenatal care, 
while 72% and 64% received no second and third trimester prenatal 
care, respectively.  It was not reported at what trimester or trimesters the 
substance abuse was taking place, but might be assumed that abuse 
during any trimester would be harmful.  Also troubling was the finding 
that child abuse and/or child neglect had been reported against 78% of 
biological mothers while the child in the study was in their care.  This was 
not surprising; however, given that only 17% of children in the overall 
sample and 16% of children in the methamphetamine-only exposed 
group were living with their biological parent at the time of their visit to 
the clinic.  The others had been removed from the biological mothers’ 
care as 56% of children in the overall sample and 59% of children in the 
methamphetamine-only group lived with either a foster or adoptive 
parent at the time of their clinic visit.  Further, 82% of biological mothers 
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in the methamphetamine-only group reported being victims of domestic 
violence and only 21% reported “married” as their marital status.  Finally, 
the mean education level of biological mothers was 10th grade.  These 
findings indicate, prenatal exposure aside, just how detrimental it is for a 
child to be raised in a home in which methamphetamine is the primary 
drug of choice.  It might be assumed that in many of these homes, 
methamphetamine was not only being used, but manufactured as well.  
This also underscores the harmful environmental effects of post-natal 
exposure to the drug.  It might also be suggested that marital status, 
education level, and prenatal care could be resilience factors for these 
women and their children. 
 For children in the sample, the mean length of time with their 
current primary caregiver was 24 months while the mean length of time 
for children in the methamphetamine-only group was 15 months at the 
time of their clinic visit.  As the vast majority of children in this study had 
multiple placements in their history, could this indicate that those with 
methamphetamine-only exposure were more difficult to place or were 
less likely to remain in a placement for as long a time as children with 
other exposures?  It was beyond the scope of this study to answer that 
question. 
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 Results of ANOVAs showed various findings.  Although no 
significant differences were found between exposure groups on scores of 
cognitive development, emotional development, and behavioral 
development, a nonsignificant difference was found on language 
development.  Additionally, significant differences were found between 
exposure groups on scores of motor development and head 
circumference measurements, indicating that when compared to the 
normative sample, the methamphetamine-exposed group had delayed  
motor development, as well as smaller head circumference.  This seems 
to suggest that prenatal exposure to methamphetamine is as harmful as 
prenatal exposure to other substances; however, it does not appear to 
cause increased cognitive, language, emotional, or behavioral damage, 
nor does it appear to compound the effects of other drugs.  However, 
findings of significant differences in the motor development and head 
circumference categories seem to indicate that these areas may be at 
risk of increased damage through prenatal exposure to 
methamphetamine. 
 When compared to children in the normative samples, significant 
differences were observed in children with methamphetamine-only 
exposure in the areas of cognitive functioning, language functioning, 
motor functioning, emotional functioning, and head circumference.  This 
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indicates that children with methamphetamine exposure had lower 
cognitive, language, motor, and emotional functioning scores, and a 
smaller head circumference than did children in the normative sample.  
However, longitudinal research has also shown that family income and 
poverty status were significant predictors of IQ scores in five-year-olds 
with low socioeconomic status (SES) being positively related to IQ 
scores (McLoyd, 1998).  Without clear information regarding the SES of 
the children in this study, it is not possible to determine whether lower 
scores on the cognitive assessments were related to the prenatal drug 
exposure, the family’s SES, or both.  Although differences were not 
found to reach significance in the number of behavioral problems 
exhibited by children in the methamphetamine-only group when 
compared to the normative sample, significance was reached in the 
intensity of the problems exhibited.  This could suggest that children with 
prenatal methamphetamine exposure are a more challenging group for 
caregivers, and thus are more difficult to place. 
 A caveat exists in the results of the motor skills.  In examination of 
overall, gross, and fine motor functioning, the methamphetamine-only 
group was found to have statistically significantly lower scores than the 
normative sample.  However, further examination found that while the 
methamphetamine-only male group was statistically significantly different 
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in overall, gross, and fine motor functioning, the methamphetamine-only 
female group did not statistically significantly differ from the normative 
female group on measures of total motor skills.  This was also shown in 
gross motor functioning, as well as fine motor functioning.  Although the 
sample of methamphetamine-only females was very small (7), it is 
possible that a true difference exists between the effects of 
methamphetamine on males and females.  This appears to be an area in 
which increased research might be valuable. 
 Although the height, weight, and head circumference of 
methamphetamine-only exposed boys and girls were found to be lower 
than the normative sample, weight and head circumference were very 
close to the mean of the normative sample (50th percentile).  However, 
height fell into the 30th percentile for the methamphetamine-only group, 
significantly lower than would be expected for children in the targeted 
age groups.  Again, further research into these differences may be 
warranted by these findings. 
 These findings hold several implications for the field of 
psychology.  While drug abuse programs now exist in most major cities 
across the country, programs for the pregnant addict are less prevalent.  
Clearly, programs that emphasize prenatal care, as well as counseling 
and psychological care, should be more available to drug-abusing 
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pregnant women.  Programs should emphasize information on having a 
healthy baby and the effects of methamphetamine exposure on infant 
development, along with providing comprehensive care for those who 
seek it.  In each of these instances, the opportunity exists for 
psychologists/counselors to intervene and perhaps lessen the damage 
inflicted upon unborn children.  An additional area in which 
methamphetamine abusing pregnant women might receive intervention 
is suggested in this study’s finding that these women had a mean 
education level of 10th grade.  School counselors, as well as counselors 
in alternative education programs should be alert to girls in their care 
who are pregnant in order to provide appropriate information, education, 
and referrals regarding methamphetamine use while pregnant.  While 
prenatal methamphetamine exposure is a growing problem for all ethnic 
groups, findings in this study, as well as others, indicate that American 
Indian children and their mothers are growing in numbers of 
methamphetamine exposure and methamphetamine abuse.  This is a 
prime area for information regarding the detriments of prenatal 
methamphetamine exposure to be relayed.   Perhaps, this information 
could be provided through counselors that work in medical and/or mental 
health clinics that provide services to this ethnic group, in particular.   As 
more newborn infants and children with prenatal methamphetamine 
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exposure are encountered by health care professionals, it is increasingly 
important to identify these drug-exposed infants as early as possible.  
Assessments for motor development, with measures such as the Bailey 
Scales of Infant and Toddler Development (Bayley, 2006), along with 
measurements for head circumference could alert professionals to 
conduct a more extensive interview with mothers and, when appropriate, 
expedite interventions for these children.  Additionally, given that this 
study found 78% of methamphetamine abusing biological mothers had 
child abuse/neglect reported against them, it will also be important for 
professionals to be vigilant in scrutinizing for children who could be in 
dangerous situations.  Furthermore, that 82% of biological mothers in the 
methamphetamine abusing group reported being victims of domestic 
violence, it would also be imperative for counselors in domestic violence 
shelters to be alert for signs of methamphetamine use/abuse in pregnant 
women and women with young children in order to offer assessment or 
intervention.  This study also showed that the vast majority of children 
with prenatal methamphetamine exposure had multiple placements in 
their history.  This might be another opportunity for professionals with 
child welfare to identify these children through assessment referrals and 
thus begin intervention sooner, rather than later.  Finally, an intervention 
component that it is of paramount importance is enhancing normal infant 
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development and ensuring a strong caregiver-infant bond.  This type of 
education should begin early enough so that caregivers can learn 
appropriate and effective caregiving and avoid compounding the 
problems of the already at-risk infant.  Professionals in hospitals, as well 
as those in human services positions are in an excellent position to direct 
mothers (biological, foster, or adoptive) to appropriate counseling 
programs in order to strengthen the parent-child bond and offer early 
support for those who will be caring for an infant with prenatal 
methamphetamine exposure. 
Limitations and Future Research 
 Given the preliminary nature of this study, the conclusions should 
be interpreted in light of several limitations.  The data from this study 
were obtained via retrospective report, so faulty reporting of prenatal 
drug exposure was a concern.  Future studies would benefit from 
prospective investigations of the effects of prenatal drug exposure, with 
subjects being identified by positive toxicology screens at some point 
during the pregnancy or immediately after birth.  According to a 
publication issued by the Arizona Department of Economic Security 
(2005), meconium testing is the most reliable and comprehensive 
toxicology screen in newborns.  Meconium formation starts between 16 
to 20 weeks gestation, and continues until birth.  Newborn meconium 
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testing identifies most substances used by the mother after 20 weeks, 
such as: cocaine, marijuana, opiates, barbiturates, benzodiazepines, 
amphetamines, and PCP.  Future research might extend this 
investigation to also look at gestational age of prenatal 
methamphetamine exposure to explore whether there are particular 
gestational stage effects on cognitive development, language 
development, motor development, emotional development, behavioral 
development, and head circumference measurements, and, if so, what 
those effects might be. 
 As toxicology was not available, many of the retrospective records 
did not list the specific substances to which the subjects were prenatally 
exposed.  Therefore, the sample in this study was limited by the lack of 
control for substances of abuse other than methamphetamine.  Future 
research could be strengthened by the use of subjects who were 
positively identified as having prenatal exposure to methamphetamine 
only or, perhaps, by knowledge of which specific drug was involved in 
the subjects’ exposure. 
 An additional limitation of the current study is that it involved 
subjects who had experienced in-vivo exposure; however, their 
environmental exposure to drugs and alcohol was not documented.  The 
physical and family environments provided by parents who use 
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methamphetamine often are chaotic, neglectful, and abusive, exposing 
children to criminal behavior and dangerous substances (Altshuler, 
2005).  Common behavioral issues exhibited by chronic 
methamphetamine users include unpredictability, paranoia, auditory and 
visual hallucinations, compulsive behavior, labile moods, rages, and 
depressed mood (Srisurapanont et al., 2003).  Sustained use of 
methamphetamine causes memory deficits, learning impairment, and 
difficulty in processing information (Meredith et al., 2005).  Current 
studies have not yet demonstrated whether some of the effects of 
methamphetamine are reversible, given adequate time.  As a result, 
children whose parents use methamphetamine are likely to experience 
their parent’s poor decision-making abilities, with both lack of supervision 
and basic necessities neglected.  Additionally, characteristics of 
methamphetamine production and use create physical and 
environmental conditions that can be extremely detrimental.  Children of 
users and producers are exposed to toxic by-products of the drug’s 
manufacture that contaminate the places that serve simultaneously as 
the parent’s methamphetamine lab and the child’s home (Lineberry & 
Bostwick, 2006).  Important future research could include the effects of 
environmental exposure to methamphetamine on children. 
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 The archival nature of the study resulted in missing data, 
especially with respect to various assessment scores and demographic 
information.  The use of prospective, methodologically sound studies 
would eliminate this limitation.  Also included in this limitation is the lack 
of SES information for families of the children in this study.  It would be 
important for future studies to address this issue considering the impact 
that low SES has on development, most notably cognitive functioning 
scores. 
 An additional limitation of the current study was the lack of a 
control population.  Only children who have been prenatally exposed to 
drugs and alcohol receive developmental evaluations at the clinic in this 
study, so inclusion of a non-drug exposed control group was not 
possible.  Future research should aim to compare groups matched on 
demographic variables in order to control for the effects of these 
variables. 
 Finally, although the current study is not without limitations, there 
are also notable strengths.  A noteworthy strength is the relatively large 
size for research in this area.  To date, most studies examining the 
effects of prenatal methamphetamine exposure on the developing fetus 
have been limited by small sample sizes (Chang et al., 2004; Smith et 
al., 2001).  Additionally, this study examined a more homogenous 
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sample of children in that it included children with methamphetamine-
only prenatal exposure in addition to children with methamphetamine 
plus other substances, as well as children with prenatal exposure to 
substances not including methamphetamine.  The inclusion of the 
methamphetamine-only group is indeed a strength of this study.
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Appendix A 
Child, Biological Mother, and Current Primary Caregiver 
Demographic Information Table 
 
Demographic Information – Child (n = 1556)      
Child Gender 
 Male          875 
 Female          677 
 Unknown             4 
 
Child Age (in months) 
 Minimum             2 
 Median            36 
 Mean            38.23 
 Maximum           96 
 
Child Race 
 Caucasian         804 
 African American        293 
 American Indian        190 
 Multiracial         174 
 Hispanic           75 
 Asian              5 
 Other              2 
 Unknown           13 
 
Child Height Percentile 
 Minimum             0.00 
 Median            25.00 
 Mean            34.74 
 Maximum           98.00 
 Unknown           68 
 
Child Weight Percentile 
 Minimum             1.00 
 Median            50.00 
 Mean            45.36 
 Maximum           99.00 
 Unknown           66 
 
Child Head Circumference Percentile 
 Minimum             1.00 
 Median            40.00 
 Mean            40.26 
 Maximum           99.00 
 Unknown           74 
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Demographic Information – Biological Mother (n = 1556)     
Prenatal Care 1st Trimester 
 Yes          334 
 No        1200 
 Unknown           22 
 
Prenatal Care 2nd Trimester 
 Yes          479 
 No        1055 
 Unknown           22 
 
Prenatal Care 3rd Trimester 
 Yes          519 
 No        1015 
 Unknown           22 
 
Biological Mother Education Level 
 Minimum             1.00 
 Median            11.00 
 Mean            10.73 
 Maximum           18.00 
 Unknown         674 
 
Biological Mother Marital Status 
 Single          712 
 Married          316 
 Divorced           69 
 Cohabitate           57 
 Separated           30 
 Widow              2 
 Unknown         370 
 
Biological Mother Race 
 Caucasian         918 
 African American        253 
 American Indian        151 
 Multiracial             0 
 Hispanic           58 
 Asian              5 
 Other            42 
 Unknown         129 
 
Abuse/Neglect Reported 
 Yes          398 
 No        1133 
 Unknown           25 
 
Domestic Violence Reported 
 Yes          369 
 No        1162 
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 Unknown           25 
 
Demographic Information – Current Primary Caregiver (n = 1556)   
Length of Time with Current Primary Caregiver (in months) 
 Minimum             0 
 Median            18 
 Mean            24 
 Maximum           87 
 Unknown           22 
 
Relationship with Current Primary Caregiver 
 Biological Parent        268 
 Foster Parent         542 
 Adoptive Parent        331 
 Grandparent         276 
 Other Relative         112 
 Other            13 
 Unknown           14 
 
Current Primary Caregiver Race 
 Caucasian       1030 
 African American        223 
 American Indian          91 
 Multiracial             0 
 Hispanic           38 
 Asian              0 
 Other            21 
 Unknown         153 
 
Current Primary Caregiver Marital Status 
 Single          256 
 Married          950 
 Divorced           87 
 Cohabitate           16 
 Separated           33 
 Widow            37 
 Unknown         177 
 
Current Primary Caregiver Education Level 
 Minimum             0.00 
 Median            12.00 
 Mean            11.89 
 Maximum           24.00 
 Unknown         163 
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Appendix B 
Child Demographic Information 
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Appendix C 
Biological Mother Demographics 
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Appendix D 
Current Primary Caregiver Demographics 
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Appendix E 
Boxplots for Variables by Exposure 
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Appendix F 
Estimated Marginal Means of Eyberg Scales 
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Appendix G 
Methamphetamine-Only Height, Weight, 
and Head Circumference Graphs 
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Appendix H 
Mean of Height, Weight, and 
Head Circumference by Gender Graphs 
 
 
 
Multidimensional Functioning 
 150
 
